Search result

Animal/Tissue Order List

1 - 1226 / total 1226

Order	Amimal	Tissue	JCRB No.	Cell Name	Profile
bovine:blastcyst Top
Ask to JCRB	bovine	blastcyst	JCRB1981	BT-J	bovine trophoblastic cell line
bovine:blastcyto Top
Ask to JCRB	bovine	blastcyto	JCRB1955	BT-F	bovine trophoblastic cell line
bovine:cornea Top
Japan Domestic use only	bovine	cornea	JCRB9129	BCE C/D-1b	Bovine corneal endothelial cell line.
bovine:kidney Top
Japan Domestic use only	bovine	kidney	JCRB0008	CKT-1	useful to assay bovine adenovirus 3
Japan Domestic use only	bovine	kidney	IFO50003	CKT-1	This cell line is useful to produce and assay bovine adinovirus 3 in vitro. (J. Virol., 16, 621 (1975)). CKT-1 is a clone of CKT.
Japan Domestic use only	bovine	kidney	JCRB9028	MDBK (NBL-1)	established from normal kidney
Japan Domestic use only	bovine	kidney	JCRB0716	MDBK.P3	normal kidney, MDBK derivative, no serum required
bovine:lung Top
Japan Domestic use only	bovine	lung	JCRB9038	EBTr (NBL-4)	embryonic trachea
bovine:trophoblast Top
Ask to JCRB	bovine	trophoblast	JCRB1927	BT-A	bovine trophoblastic cell line
Ask to JCRB	bovine	trophoblast	JCRB1935	BT-B	bovine trophoblastic cell line
Ask to JCRB	bovine	trophoblast	JCRB1936	BT-D	bovine trophoblastic cell line
bovine:vascular system Top
Japan Domestic use only	bovine	vascular system	JCRB9025	CPA	pulmonary artery normal endothelial cell
Japan Domestic use only	bovine	vascular system	JCRB9022	CPAE	pulmonary artery normal endothelial cell
Japan Domestic use only	bovine	vascular system	IFO50154	FBHE	Normal diploid endothelial cells with limited life span. FGF-dependent for survival.
Japan Domestic use only	bovine	vascular system	JCRB0099	HH	carotid artery normal endothelial cell
Japan Domestic use only	bovine	vascular system	JCRB0155	NM-1	Newly established primary bovine cell line established from artery which is confirmed to be free from BVDV contamination.
cat:kidney Top
	cat	kidney	JCRB9035	CRFK	kidney, BVD antigen negative
cat:neural Top
	cat	neural	JCRB9125	PG-4(S+L-)	brain derived cell line transformed with Moloney murine sarcoma virus, support type C retroviruses
chicken:hemo-lymphocytic Top
Japan Domestic use only	chicken	hemo-lymphocytic	JCRB9130	DT40	avian leukosis virus (ALV)-induced lymphomas
chicken:liver Top
Japan Domestic use only	chicken	liver	JCRB0237	LMH	hepatocelluler carcinoma, diethylnitrosamine induced
chimpanzee:hemo-lymphocytic Top
Japan Domestic use only	chimpanzee	hemo-lymphocytic	JCRB1165	HSP-239	Peripheral blood lymphocyte cell line of chimpanzee.
Japan Domestic use only	chimpanzee	hemo-lymphocytic	JCRB1177	HSP-250	Peripheral blood lymphocyte cell line of chimpanzee.
dog:kidney Top
	dog	kidney	JCRB9029	MDCK (NBL-2)	established from normal kidney, susceptible for many viral species
	dog	kidney	IFO50071	MDCK (NBL-2)	Epitherial-like cell line established from normal kidney of dog, susceptible for many viral species.
	dog	kidney	JCRB0717	MDCK.P3	normal kidney, MDCK derivative, no serum required
dog:lung Top
	dog	lung	JCRB1453	CLAC	Canine lung adenocarcinoma cell line including cancer stem cells (0.75%) in sidepopulation (SP).
goat:esophagus Top
Japan Domestic use only	goat	esophagus	JCRB9037	Ch 1 Es	Fibroblastic cell line from normal fetal goat esophagus.
guinea pig:embryo Top
	guinea pig	embryo	JCRB9036	104C1	fetal carcass, benzo(a)pyrene transformed, diploid
guinea pig:hemo-lymphocytic Top
	guinea pig	hemo-lymphocytic	IFO50210	L2C	Leukemic cells derived from Guinea pig maintainable only by transplantation.
hamster, Chinese:lung Top
	hamster, Chinese	lung	JCRB1105	AIG	anchorage-independent mutant of CHL
	hamster, Chinese	lung	JCRB0030	CHL/IU(IVGT)	Chinese hamster lung cells. Standard cell line for chromosome aberation test.
	hamster, Chinese	lung	JCRB1102	cs-17-25	Temperature sensitive mutant of Chinese hamster lung cell line.
	hamster, Chinese	lung	JCRB1103	cs-19-36	Temperature sensitive mutant of Chinese hamster lung cell line.
	hamster, Chinese	lung	JCRB1104	cs-20-5	temperature sensitive mutant of Chinese hamster lung cell line.
	hamster, Chinese	lung	JCRB1096	hs-103-3	Temperature sensitive mutant of Chinese hamster lung cell line.
	hamster, Chinese	lung	JCRB1097	hs-164-2	Temperature sensitive mutant of Chinese hamster lung cell line.
	hamster, Chinese	lung	JCRB1098	hs-171-1	Temperature sensitive mutant of Chinese hamster lung cell line.
	hamster, Chinese	lung	JCRB1099	hs-172-3	Temperature sensitive mutant of Chines hamster lung cell line.
	hamster, Chinese	lung	JCRB1100	hs-211	Temperature sensitive mutant of Chinese hamster lung cell line.
	hamster, Chinese	lung	JCRB1101	hs-222-3	temperature sensitive mutant of Chinese hamster lung cell line.
	hamster, Chinese	lung	JCRB0626	TG1	V79 derivative, 6-thioguanine-resistant
	hamster, Chinese	lung	JCRB0603	V79	fibroblast
	hamster, Chinese	lung	IFO50082	V79 379A	lung, fibroblast, widely used in somatic genetics
	hamster, Chinese	lung	JCRB0707	V79 HPRT~	V79 derivative, HPRT-deficient
	hamster, Chinese	lung	JCRB0219	V79-6TG	6-thioguanine-resistant V79 cell line
	hamster, Chinese	lung	JCRB0119	YG10003	salmonella O-acetyltransferase gene introduced CHL cells
	hamster, Chinese	lung	JCRB0120	YG10007	human monomorphic N-acetyltransferase gene introduced CHL cells
	hamster, Chinese	lung	JCRB0121	YG10008	human polymorphic N-acetyltransferase gene transfected CHL cells
hamster, Chinese:ovary Top
	hamster, Chinese	ovary	JCRB0136.2	CHO(pMAM-HSluc)	pMAM-HSluc transfected CHO-K1, HSP 70B gene promoter and luciferase reporter gene introduced
	hamster, Chinese	ovary	JCRB0136.1	CHO(pMAM-luc)	pMAM-luc transfected CHO-K1, luciferase activated by dexamethasone
	hamster, Chinese	ovary	JCRB9018	CHO-K1	subclone of CHO (Chainese hamster ovary) cells
	hamster, Chinese	ovary	IFO50414	CHO-K1	CHO-K1 cells are useful for isolation of nutritionally deficient mutants.
	hamster, Chinese	ovary	JCRB0218	CHO/HGPRT	HGPRT deficient chinese hamster ovary (CHO) cells.
	hamster, Chinese	ovary	JCRB1616	hTf/CHO-S #17	This cell line produce human transferrin.
	hamster, Chinese	ovary	JCRB1629	hTf/CHO-S #17/sf	This cell line produce human transferrin (cell freezed by 10% DMSO+90%FBS).
	hamster, Chinese	ovary	JCRB1629.01	hTf/CHO-S #17/sf	This cell line produce human transferrin (cell freezed by Cryoprotective Medium).
	hamster, Chinese	ovary	JCRB1631	hTf/CHO-S #29/sf	This cell line produce human transferrin (cell freezed by 10% DMSO + 90% FBS).
	hamster, Chinese	ovary	JCRB1631.01	hTf/CHO-S #29/sf	This cell line produce human transferrin (cell freezed by Cryoprotective Medium).
	hamster, Chinese	ovary	JCRB1636	pREP4 c/CHO-S #5/sf	pREP4-cont transfected CHO-S cells (cell freezed by 10% DMSO + 90% FBS).
	hamster, Chinese	ovary	JCRB1636.01	pREP4 c/CHO-S #5/sf	pREP4-cont transfected CHO-S cells (cell freezed by Cryoprotective Medium).
	hamster, Chinese	ovary	JCRB1626	pREP4 cont/CHO-S #5	pREP4-cont transfected CHO-S cells (cell freezed by 10% DMSO + 90% FBS).
hamster, Syrian:embryo Top
	hamster, Syrian	embryo	JCRB0217	DSPT200	fetus fibroblast transformed cell
	hamster, Syrian	embryo	IFO50018	NIL	transformed from hamster fibroblast
	hamster, Syrian	embryo	IFO50426	NIL-SF2	NIL subline adapted to serum-free medium
	hamster, Syrian	embryo	IFO50367	SHOK	This cell line is useful for transformation assay.
hamster, Syrian:hemo-lymphocytic Top
	hamster, Syrian	hemo-lymphocytic	JCRB1362	HCT-2	Hamster spleen lymphocytes transformed by human T-cell leukemia virus type I.
	hamster, Syrian	hemo-lymphocytic	JCRB1208	HM-1	Hamster macrophage cell line from Syrian hamster transplanted with human umbilical cord leukocytes.
hamster, Syrian:kidney Top
	hamster, Syrian	kidney	JCRB9020	BHK-21(C-13)	kidney, subclone of BHK-21
hamster, Syrian:lung Top
	hamster, Syrian	lung	JCRB0221	HT100	lung, new born
hamster, Syrian:melanoma Top
	hamster, Syrian	melanoma	JCRB9087	RPMI 1846	melanotic melanoma
human:adrenal cortex Top
	human	adrenal cortex	JCRB9069	SW-13	Human adenocarcinoma derived from adrenal cortex.
human:bile duct Top
	human	bile duct	JCRB1657	HuCCA-1	Human cell line derived from cholangiocarcinoma.
	human	bile duct	JCRB1775	KKK-D068	Human well differentiated tubular adenocarcinma cell line established from biliary tract. (with micropapillary foci)
	human	bile duct	JCRB1777	KKK-D131	Human well differentiated tubular adenocarcinoma cell line established from biliary tract.
	human	bile duct	JCRB1778	KKU-023	Human well differentiated cholangiocarcinoma cell line established from biliary tract.
human:bladder Top
	human	bladder	JCRB0710	EJ-1	The cell line EJ-1 was identified to be the same cell line as the T24.
	human	bladder	JCRB1148	KMBC-2	Urinary bladder cancer cell line
	human	bladder	JCRB0711	T24	urinary bladder carcinoma
human:blood Top
	human	blood	JCRB1972	Kit225	IL-2 dependent T-cell chronic lymphocytic leukemia (T-CLL) cell line
human:bone marrow stroma Top
	human	bone marrow stroma	IFO50477	FS-1	This cell line produces IL-6 and SCF into its supernatant. Although this cell line was reported as immortalized cell line, the ampoules preserved in the cell bank hardly proliferated.
human:cartilage Top
	human	cartilage	JCRB1137	UE6E7TC-4	Human immortalized mesenchymal cells derived from dedifferentiated chondrocyte, expressing mesenchymal stem cell markers.
human:cerebral tumor Top
	human	cerebral tumor	JCRB1868	AT/RT	atypical teratoid/rhabdoid tumor
human:colon Top
	human	colon	IFO50483	CCD-33Co	Human fibroblast cell line established from normal colon. The ampoules preserved in the cell bank hardly proliferate.
	human	colon	JCRB0208	CCK-81	adenocarcinoma
	human	colon	JCRB0257	CoCM-1	Human tumor cell line of the moderately differentiated adenocarcinoma from descending colon.
	human	colon	JCRB0226	COLO201	adenocarcinoma
	human	colon	JCRB0225	COLO320 DM	Human colon carcinoma cell line with double minute chromosomes.
	human	colon	JCRB9094	DLD-1	adenocarcinoma
	human	colon	JCRB1998	KE-24	poorly differentiated adenocarcinoma (signet-ring cell type) established from primary tumor.
	human	colon	JCRB4003	KE-43	moderately differentiated adenocarcinoma established from primary tumor. Transition to poorly differentiated adenocarcinoma by passage.
	human	colon	JCRB4004	KE-43C4	Well-differentiated adenocarcinoma obtained by cloning KE-43
	human	colon	JCRB9083	LoVo	adenocarcinoma, carcinoembryonic antigen-producing
	human	colon	IFO50067	LoVo	adenocarcinoma, carcinoembryonic antigen-producing
	human	colon	JCRB1339	NCC-CoC-K115B	Human B-cell line (transformed by EBV) derived from colon cancer patient.
	human	colon	JCRB1333	NCC-CoC-K115L	Human colon cancer cell line (metastasis peripheral lymph node).
	human	colon	JCRB1320	NCC-CoC-K115P	Human colon cancer cell line.
	human	colon	JCRB1022	OUMS-23	A human colon carcinoma cell line established from metastatic pericardial fluid.
	human	colon	JCRB1963	UCCA-21	Derived from colorectal cancer with ulcerative colitis. Isolated as well-differentiated adenocarcinoma by cloning. Paneth cells included.
	human	colon	JCRB0224	WiDr	adenocarcinoma
	human	colon	IFO50043	WiDr	adenocarcinoma
human:duodenum Top
	human	duodenum	JCRB1946	AkuNEC	Cachexia-inducing cell line, (established from duodenal neuroendocrine carcinoma TCC-NECT-2)
	human	duodenum	JCRB1916	TCC-NECT-2	Duodenal neuroendocrine tumor. Derived from metastatic site: Ascites.
human:embryo Top
	human	embryo	IFO50297	HE-1	Normal diploid fibroblasts with limited life span.
	human	embryo	JCRB0432	KMS-6	fibroblast, normal diploid
	human	embryo	JCRB0433	KMST-6	fibroblast, immortalized by 60Co irradiation, derivative of KMS-6
	human	embryo	JCRB0220	NTI-4	Normal human fibroblast.
	human	embryo	JCRB0222	NTI-5	Normal human cells.
	human	embryo	JCRB1051	OUMS-24/P6X	Human normal cells immortalized by pCDM8-p53 and X-ray irradiation.
	human	embryo	JCRB1006.0	OUMS-36	Normal human embryo fibroblast cell.
	human	embryo	JCRB1006.1	OUMS-36T-1	hTRT gene transfected normal human embryo fibroblast cell line.
	human	embryo	JCRB1006.1F	OUMS-36T-1F	fibroblast, immortalized by hTRT, derivative of OUMS-36
	human	embryo	JCRB1006.2	OUMS-36T-2	hTRT gene transfected normal human embryo fibroblast cell line.
	human	embryo	JCRB1006.2F	OUMS-36T-2F	fibroblast, immortalized by hTRT, derivative of OUMS-36
	human	embryo	JCRB1006.3	OUMS-36T-3	hTRT gene transfected normal human embryo fibroblast cell line.
	human	embryo	JCRB1006.3F	OUMS-36T-3F	Human normal diploid cells transfected with hTRT gene
	human	embryo	JCRB1006.4	OUMS-36T-4	hTRT gene transfected normal human embryo fibroblast cell line.
	human	embryo	JCRB1006.4F	OUMS-36T-4F	Immortalized normal human cell with hTRT gene.
	human	embryo	JCRB1006.5	OUMS-36T-5	hTRT gene transfected normal human embryo fibroblast cell line.
	human	embryo	JCRB1006.5F	OUMS-36T-5F	fibroblast, immortalized by hTRT, derivative of OUMS-36
	human	embryo	JCRB1006.6	OUMS-36T-6	hTRT gene transfected normal human embryo fibroblast cell line.
	human	embryo	JCRB1006.6F	OUMS-36T-6F	fibroblast, immortalized by hTRT, derivative of OUMS-36
	human	embryo	JCRB1006.7	OUMS-36T-7	hTRT gene transfected normal human embryo fibroblast cell line.
	human	embryo	JCRB1006.7F	OUMS-36T-7F	Human normal fibroblast transformed with hTRT gene.
	human	embryo	JCRB1006.8	OUMS-36T-8	hTRT gene transfected normal human embryo fibroblast cell line.
	human	embryo	JCRB1006.8F	OUMS-36T-8F	fibroblast, immortalized by hTRT, derivative of OUMS-36
human:epidermoid carcinoma Top
	human	epidermoid carcinoma	JCRB0004	A-431	epidermoid carcinoma, high expression of EGF-receptor
	human	epidermoid carcinoma	JCRB9009	A-431	epidermoid carcinoma, high expression of EGF-receptor
	human	epidermoid carcinoma	IFO50411	A-431	epidermoid carcinoma, high expression of EGF receptor
human:esophagus Top
	human	esophagus	JCRB1883	KE-3	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
	human	esophagus	JCRB1911	KE-5	Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
	human	esophagus	JCRB1915	KE-6	Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1483	KYAE-1	Human esophageal adenocarcinoma cell line.
Japan Domestic use only	human	esophagus	JCRB1595	KYAE-2	Human esophageal adenocarcinoma cell line.
Japan Domestic use only	human	esophagus	JCRB1064	KYSE110	Poorly differentiated squamous carcinoma cell line from human esophagus cancer.
Japan Domestic use only	human	esophagus	JCRB1449	KYSE1140	Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1457	KYSE1170	Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1421	KYSE1190	Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1444	KYSE1230	Human spindle cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1456	KYSE1240	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1462	KYSE1250	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1434	KYSE1260	Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1063	KYSE140	Human esophageal cancer cell line.
Japan Domestic use only	human	esophagus	JCRB1432	KYSE1440	Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1095	KYSE150	Poorly differentiated squamous carcinoma cell line from human esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1082	KYSE170	Human squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1083	KYSE180	Human well differentiated squamous cell carcinoma from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1460	KYSE1860	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1426	KYSE190	Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1086	KYSE220	Human squamous cell carcinoma from esophagus.
Japan Domestic use only	human	esophagus	JCRB1468	KYSE2270	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1472	KYSE2300	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1424	KYSE2400	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1087	KYSE270	Human squamous cell carcinoma from esophagus cancer.
Japan Domestic use only	human	esophagus	JCRB1467	KYSE2710	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1452	KYSE2780	Human squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1469	KYSE2880	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB0188	KYSE30	Well differentiated human suamous cell carcinoma from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1463	KYSE3210	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1425	KYSE3410	Human squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1428	KYSE350	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1495	KYSE3650	Human squamous cell carcinoma cell line established from recurrent cancer (esophageal cancer).
Japan Domestic use only	human	esophagus	JCRB1481	KYSE3940	moderate differenciated squamous cell carcinoma, stage 3
Japan Domestic use only	human	esophagus	JCRB1419	KYSE410	Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1430	KYSE450	Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB0189	KYSE50	Stop providing for the issue of quality control. (Please contact us for more information) Poorly differentiated human squamous cell carcinoma from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1436	KYSE510	Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1439	KYSE520	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1443	KYSE590	Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB0190	KYSE70	Poorly differentiated human squamous cell carcinoma from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1445	KYSE770	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1418	KYSE790	Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1422	KYSE850	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only	human	esophagus	JCRB1417	KYSE960	Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
	human	esophagus	JCRB0262	T.T	Human squamous cell carcinoma derived from esophageal cancer.
	human	esophagus	JCRB0261	T.Tn	Human squamous cell carcinoma from oral cavity via mouse transplantation.
Japan Domestic use only	human	esophagus	JCRB1512	TYUC-1	Human esophageal small cell carcinoma cell line established from mouse xenograft.
human:glioblastoma Top
	human	glioblastoma	IFO50492	AM-38	glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-sensitive
human:glioma Top
	human	glioma	IFO50356	KNS-42	glioma, GFAP-positive, S-100 and NSE-negative
	human	glioma	JCRB1569	NP 5	Human cell line derived from human glioma.
human:HeLa-contaminant Top
	human	HeLa-contaminant	JCRB9066	Chang Liver	The Chang Liver cell line has been identified historically as a subline of the HeLa.
	human	HeLa-contaminant	IFO50016	Chang Liver	Hela markers*
	human	HeLa-contaminant	JCRB1070	HSGc-C5	Human undifferentiated carcinoma cell line from floor of mouth (HeLa evidences observed).
	human	HeLa-contaminant	JCRB0073	J-111	The cell line deposited as a human acute monocytic leukemia but many data show this cell line is a subline of the HeLa.
	human	HeLa-contaminant	IFO50005	J-111	HeLa markers*
	human	HeLa-contaminant	JCRB9027	KB	The cell line KB has been known that this cell line is a subline of the HeLa.
	human	HeLa-contaminant	IFO50004	WISH	Cells were reported to established from human aminion but later HeLa markers were observed.
human:hemo-lymphocytic Top
	human	hemo-lymphocytic	JCRB0097	A4/Fuk	lymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing
	human	hemo-lymphocytic	JCRB0117	B104	Human B cell lymphoma cell line with EBNA(-). IgD and IgM were expressed on the surface of cells.
	human	hemo-lymphocytic	JCRB0071	BALL-1	Acute lymphoblastoid leukemia (ALL) cell line from human.
	human	hemo-lymphocytic	JCRB0033	CCRF-CEM	leukemia, acute T lymphoblastic
	human	hemo-lymphocytic	JCRB9023	CCRF-CEM	Human cell line established from patient with acute lymphoblastic leukemia.
	human	hemo-lymphocytic	IFO50412	CCRF-CEM	leukemia, acute T lymphoblastic
	human	hemo-lymphocytic	JCRB0031	CCRF-HSB2	Human T-lymphoblastic leukemia cell line from implanted tumor in Syrian hamster.
	human	hemo-lymphocytic	IFO50026	CCRF-SB	Karyotypes appeared normal diploid. This cell line does not synthesize immunogloblins.
	human	hemo-lymphocytic	IFO50430	CMK-11-5	This cell line posseses more mature characteristics than CMK-86 cells.
	human	hemo-lymphocytic	IFO50428	CMK-86	This cell line expresses GPIIb/IIIa. Contains alpha-granule. Contains platelet peroxidase activity.
	human	hemo-lymphocytic	JCRB1067	CPT-K5	Mutant cell line derived from human ALL cell line, RPMI8402.
	human	hemo-lymphocytic	JCRB1344	delta-47	Human myeloma cell line secreting IgD.
	human	hemo-lymphocytic	JCRB1337	DL-40	Ki-1-positive T-cell lymphoma cell line.
	human	hemo-lymphocytic	JCRB1346	FLAM-76	Interleukin-6-dependent human myeloma cell line from an agressive nonsecretory plasma cell leukemia.
	human	hemo-lymphocytic	JCRB1335	HD-70	Human Hodgkin's lymphoma cell line of B-cell origin.
	human	hemo-lymphocytic	IFO50022	HL-60	IFO strain exhibits more rapid growth compared to the original HL-60 strain. IFO strain does not respond to DMSO or TPA for differentiation unlike to original HL-60 strain.
	human	hemo-lymphocytic	JCRB0085	HL60	Promyelocytic cell line differentiated to neutrophils or macropahges by tumor promoters, vitamne D3 or cytekines. The cell line can be used for the research of the differenciation induction or analysis of some oncogenes.
	human	hemo-lymphocytic	JCRB0163	HL60(S)	Promyeloblastic cell line differentiated to neutrophils or macropahges by tumor promoters, vitamne D3 or cytekines. This HL60(S) has been independently obtained by Dr. Ishida,S. and Dr. Shudo,K.
	human	hemo-lymphocytic	JCRB0006	HL60RG	Subline of the HL60 having faster growth rate but the capabilities of the differentiation by TPA or etc were declined.
	human	hemo-lymphocytic	JCRB0041	HLCL-1	lymphocyte, peripheral
	human	hemo-lymphocytic	JCRB9062	HS-Sultan	established as plasmacytoma, but revealed as derivative of Jiyoye cell line (Burkitt's lymphoma)
	human	hemo-lymphocytic	JCRB0024	IM-9	myeloma, multiple, B lymphoblastic
	human	hemo-lymphocytic	IFO50025	IM-9	IgG-secreting B-lymphoblastic cell line.
	human	hemo-lymphocytic	JCRB0147	JKT-beta-del	The JKT-beta-del cell line isolated from the Jurkat cells{5011} by a cell sorter and lacks the surface expression of the T-cell receptor alpha/beta/CD3 complex.
	human	hemo-lymphocytic	JCRB0019	K562	Highly undifferentiated and granurocytic myelogenous leukemia cell line from blast crisis.
	human	hemo-lymphocytic	JCRB1002	K562/ADM	Adriamycine resistant derivative of K562 cell line.
	human	hemo-lymphocytic	JCRB1003	Kasumi-1	A novel leukemia cell line with an t8;21 chromosome translocation established from a patient attaked by acute myeloid leukemia(AML).
	human	hemo-lymphocytic	JCRB1410	Kasumi-10	B cell leukemia
	human	hemo-lymphocytic	JCRB0161	Kasumi-4	A novel human leukemia cell line established from a patient with chronic myelogenous leukaemia (CML) in blast crisis.
	human	hemo-lymphocytic	JCRB1398	Kasumi-5	T cell leukemia
	human	hemo-lymphocytic	JCRB1401	Kasumi-7	B cell leukemia
	human	hemo-lymphocytic	JCRB1403	Kasumi-8	B cell leulemia
	human	hemo-lymphocytic	JCRB1409	Kasumi-9	B cell leukemia
	human	hemo-lymphocytic	JCRB1411	KasumiA-541	mixed lineage leukemia
	human	hemo-lymphocytic	JCRB1416	KasumiA-554	myeloid leukemia secondary to ATL
	human	hemo-lymphocytic	JCRB1415	KasumiA-568	myeloblastic leukemia
	human	hemo-lymphocytic	JCRB1317	KCL-22	Human myeloid cell line from chronic myelocytic leukemia.
	human	hemo-lymphocytic	JCRB0065	KG-1	leukemia, acute myeloblastic
	human	hemo-lymphocytic	JCRB9051	KG-1	leukemia, acute myelogenous
	human	hemo-lymphocytic	JCRB0165	KHM-10B	Human Bukitt's lymphoma, ALL-L3 cell line. HLA-DR,CD19 and surface immunoglobulin(mu, lambda) positive. Ig gene rearrangements observed.
	human	hemo-lymphocytic	JCRB1394	KHM-2B	Human acute B-cell lymphocytic leukemia cell line with two translocations t(8;14) and t(14;18).
	human	hemo-lymphocytic	JCRB1065	Ki-JK	Human mononuclear cells with multiple nucleoli from lymphoma patient.
	human	hemo-lymphocytic	JCRB1180	KMM-1	human myeloma cell line
	human	hemo-lymphocytic	JCRB0123	KO52	leukemia, acute myeloblastic
	human	hemo-lymphocytic	JCRB0104	KU812	leukemia, chronic myeloid
	human	hemo-lymphocytic	IFO50363	KU812	leukemia, chronic myeloid
	human	hemo-lymphocytic	JCRB0104.1	KU812E	leukemia, chronic myeloid
	human	hemo-lymphocytic	JCRB0104.2	KU812F	leukemia, chronic myeloid
	human	hemo-lymphocytic	JCRB0105	KY821	leukemia, acute myeloid
	human	hemo-lymphocytic	JCRB0105.1	KY821A3	leukemia, acute myeloid, subclone of KY821
	human	hemo-lymphocytic	JCRB0114	LC4-1	leukemia, acute non T lymphoblastic
	human	hemo-lymphocytic	IFO50151	MEG-01	Contains Ph1 chromosome. Expresses megakaryoblastic markers as GPIIb/IIIa, GPIb, FVIII-related antigens, and also CD9, CDw14. It is reported that MEG-01 cells produced platelet-like particles. Morphological changes by phorbol ester.
	human	hemo-lymphocytic	IFO50473	MEG-01s	This cell line is useful for studying the differentiation and maturation of megakaryocyts.
	human	hemo-lymphocytic	IFO50294	MEG-01SSF	leukemia, chronic megakaryoblastic, MEG-01s-derivative adapted to serum-free medium
	human	hemo-lymphocytic	IFO50478	MEG-A2	This cell line is useful for studying the differentiation and maturation of megakaryocyts.
	human	hemo-lymphocytic	JCRB1404	Minami-1	follicular B cell lymphoma
	human	hemo-lymphocytic	JCRB1405	Minami-2	B cell lymphoma (Burkitt type)
	human	hemo-lymphocytic	JCRB1325	MKPL-1	A megakaryoblastic leukemia cell line from human acute myeloblastic leukemia.
	human	hemo-lymphocytic	JCRB0146	MLMA	The cells are IgD, IgM positive, hairy B-cells from human malignant lymphoma patient.
	human	hemo-lymphocytic	JCRB9048	MOLT-3	leukemia, acute lymphoblastic
	human	hemo-lymphocytic	JCRB9031	MOLT-4	leukemia, acute T lymphoblastic
	human	hemo-lymphocytic	IFO50362	MOLT-4	leukemia, acute T lymphoblastic
	human	hemo-lymphocytic	JCRB0021	MOLT-4F	leukemia, acute T lymphoblastic
	human	hemo-lymphocytic	IFO50513	MTA	leukemia, NK-like T cell line
	human	hemo-lymphocytic	JCRB0158.0	MY	Human bone marrow mononuclear cells derived from a patient having acute biphenotypic leukemia.
	human	hemo-lymphocytic	JCRB0158.1	MY-M12	Subclone of the MY, human bone marrow mononuclear cells.
	human	hemo-lymphocytic	JCRB0158.2	MY-M13	Subclone of the MY cells, human bone marrow mononulcear cells.
	human	hemo-lymphocytic	IFO50479	NAGL-1	The CDR III of this line has been sequenced.
	human	hemo-lymphocytic	JCRB1332	NALL-1	Human 'null' cell from ALL cell line.
	human	hemo-lymphocytic	JCRB1475	Nalm-6-MSH+	Human cell line derived from B cell leukemia. (MSH+, POL(WT), TK+/-)
	human	hemo-lymphocytic	IFO50040	Namalwa	This cell line produce interferon.
	human	hemo-lymphocytic	IFO50039	NC-37	lymphoblast, Contamination of Raji cells has been suspected.
	human	hemo-lymphocytic	IFO50525	NCO2	Human myelogenous leukemia cell line.
	human	hemo-lymphocytic	IFO50476	NKM-1	leukemia, acute myeloid, myeloid leukemia cells, responsive to G-CSF and M-CSF for growth
	human	hemo-lymphocytic	IFO50474	NOMO-1	This cell line is useful for studying the differentiation and maturation of monocytes.
	human	hemo-lymphocytic	JCRB1069	NOMO-1/ADM	leukemia, acute monocytic, adriamycin-resistant derivative of NOMO-1
	human	hemo-lymphocytic	IFO50475	NOMO-1s	This cell line is useful for studying the differentiation and maturation of monocytes.
	human	hemo-lymphocytic	JCRB0095	P32/ISH	lymphoma, Burkitt's
	human	hemo-lymphocytic	JCRB1345	PALL-2	Ph1 chromosome-positive human acute lymphoblastic leukemia cell line.
	human	hemo-lymphocytic	JCRB0830	PEER	Human lymphoid cell line from a case of T-leukemia lacks some typical cell surface properties of T cells.
	human	hemo-lymphocytic	JCRB9012	RAJI	lymphoma, Burkitt's
	human	hemo-lymphocytic	IFO50046	Raji	lymphoma, Burkitt's
	human	hemo-lymphocytic	JCRB9119	Ramos(RA1)	lymphoma, Burkitt's (EBV negative)
	human	hemo-lymphocytic	JCRB1334	RC-K8	A human lymphoma cell line with t(11;14) chromosome abnormality.
	human	hemo-lymphocytic	JCRB0035	RPMI 1788	established from normal blood, IgM secreting
	human	hemo-lymphocytic	IFO50037	RPMI 1788	established from normal blood, IgM secreting
	human	hemo-lymphocytic	JCRB0034	RPMI 8226	myeloma, multiple
	human	hemo-lymphocytic	IFO50013	RPMI 8226	Ig lambda light chain-secreting.
	human	hemo-lymphocytic	JCRB0115	SCC-3	Human monocytic cell line expressing Interleukin-2 receptor.
	human	hemo-lymphocytic	JCRB1170	SKNO-1	a GM-CSF dependent cell line with an t8,21 chromosome translocation estabulished from a patient attacked by acute myeloid leukemia(AML)
	human	hemo-lymphocytic	JCRB0159	SLVL	Human villous lymphoma B-cell line from splenic B-cell lymphoma.
	human	hemo-lymphocytic	JCRB1384	STR-428	Human HHV-8 negative malignant effusion lymphoma (DLBCL).
	human	hemo-lymphocytic	JCRB0112	THP-1	Human acute monocytic leukemia.
	human	hemo-lymphocytic	JCRB0112.1	THP-1	Human acute monocytic leukemia.
	human	hemo-lymphocytic	JCRB0157	TK	Human B-cell lymphoma cell line with near-triploid chromosomes with t(14;18) and p53 gene point mutation.
	human	hemo-lymphocytic	JCRB1206	TK	Brain lymphoma cell line.
	human	hemo-lymphocytic	IFO50516	TMD5	leukemia, acute B lymphoblastic, double Philadelphia chromosomes
	human	hemo-lymphocytic	IFO50038	U-937	lymphoma, diffuse histiocytic, monocyte-like characteristics
	human	hemo-lymphocytic	JCRB9021	U937	lymphoma, diffuse histiocytic, monocyte-like characteristics
	human	hemo-lymphocytic	JCRB0116.1	U937 cl1-14	lymphoma, histiocytic, highly susceptible clone of U937 for HIV
	human	hemo-lymphocytic	JCRB0116.2	U937 cl1-22	lymphoma, histiocytic, low susceptible clone of U937 for HIV
human:hepatoblastoma Top
	human	hepatoblastoma	JCRB0401	HUH-6 Clone 5	Human hepatoblastoma cell line from an infant.
human:kidney Top
	human	kidney	JCRB9068	293	transformed embryonal kidney by adenovirus (type5)
	human	kidney	JCRB0801	Caki-1	renal clear cell carcinoma
	human	kidney	JCRB9065	G-401	Rhabdoid tumor of kidney (formerly classified as Wilms' tumor)
	human	kidney	JCRB9070	G-402	renal leiomyoblastoma
	human	kidney	JCRB1484	JMU-RTK-2	Malignant rhabdoid tumor of the kidney cell line.
	human	kidney	JCRB1150	KMPC-3	Human renal pelvis.
	human	kidney	JCRB1010	KMRC-1	Human tumor cell line from kidney. Clear cell renal carcinoma cell line.
	human	kidney	JCRB1011	KMRC-2	Human tumor cell line from kidney. Clear cell renal carcinoma cell line.
	human	kidney	JCRB1071	KMRC-20	Human renal carcinoma cell line from kidney.
	human	kidney	JCRB1012	KMRC-3	Human tumor cell line from kidney. Clear cell renal carcinoma cell line. The growth is extremely slow.
	human	kidney	JCRB1014	KMRM-M1	Human renal cancer cell line metastasized to muscle.
	human	kidney	JCRB0813	VMRC-RCW	renal cell carcinoma
	human	kidney	JCRB0827	VMRC-RCZ	renal carcinoma
human:leukemia Top
	human	leukemia	JCRB1800	BALM-23	B cell leukemia cell line, ALL-L2 cell line, hypercalcemia
	human	leukemia	JCRB1843	BALM-24	B cell leukemia cell line, ALL-L3 cell line, t(8;14)(q24.1;q32)
	human	leukemia	JCRB1782	BALM-7	B cell leukemia cell line
	human	leukemia	JCRB1785	BALM-9	B cell leukemia cell line
	human	leukemia	JCRB0032	CCRF-SB	leukemia, acute B lymphoblastic
	human	leukemia	JCRB1846	EEB	Human cell line derived from erythroblastic leukemia.
	human	leukemia	JCRB0062	HEL	leukemia, erythroid
	human	leukemia	JCRB1395	Kasumi-2	B cell precursor leukemia
	human	leukemia	JCRB1004	Kasumi-3	A novel human leukemia cell line established from blast cells of a patient attaked by myeloperoxidase-negative acute leukemia.
	human	leukemia	JCRB1024	Kasumi-6	Human acute myeloid leukemia cell line with dominant negative mutation in the C/EBP alpha gene.
	human	leukemia	JCRB0156	KHYG-1	Human natural killer cell line with a p53 point mutation as a model for p53-associated leukemogenesis and a model for differentiation of NK/T cells.
	human	leukemia	JCRB1810	MOLM-13	Human acute monocytic leukemia (AML-M5a) cell line. MOLM-13 was established from the same donor as MOLM-14.
	human	leukemia	JCRB1812	MOLM-14	Human acute monocytic leukemia (AML-M5a) cell line. MOLM-14 was established from the same donor as MOLM-13.
	human	leukemia	JCRB1815	MOLM-16	Megakaryoblastic leukemia cell line derived from minimally differentiated acute leukemia (AML-M0) with myeloid/NK precursor phenotype.
	human	leukemia	JCRB1807	MOLM-6	Human multiple leukemia cell line with diverse myeloid and/or megakaryoblastic characteristics
	human	leukemia	JCRB1822	NALM-19	Biphenotypic (B-cell and myeloid cell features) leukemic cell line.
	human	leukemia	JCRB1823	NALM-20	Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive leukemic cell line.
	human	leukemia	JCRB1825	NALM-21	Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive leukemic cell line. Recurrence of the same patient as NALM-20.
	human	leukemia	JCRB1826	NALM-24	Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive acute lymphoblastic leukemia cell line. From the same patient as NALM-25
	human	leukemia	JCRB1828	NALM-25	Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive acute lymphoblastic leukemia cell line. Derived from the same patient as NALM-24
	human	leukemia	JCRB1854	NALM-29	Biphenotypic (B-cell and myeloid cell features) t(9;22)(q34;q11)-positive B-cell precursor cell line establish from acute leukemia patient.
	human	leukemia	JCRB1858	NALM-30	Biphenotypic features carrying myeloperoxidase mRNA and protein with complex Philadelphia (Ph) chromosome, t(9;22;10)(q34;q11;q22), cell line establish from acute leukemia patient. Derived from the same patient as NALM-27, NALM-28, NALM-31, NALM-32.
	human	leukemia	JCRB1856	NALM-37	B-cell precurrsor (BCP) acute lymphoblastic leukemia (ALL) cell line. Derived from the same patient as NALM-36
	human	leukemia	JCRB0094	P30/OHK	leukemia, acute non T non B lymphoblastic
	human	leukemia	JCRB0091	P31/FUJ	leukemia, acute monocytic
	human	leukemia	JCRB1319	PL-21	Human myeloid cell line derived from an acute promyelocytic leukemia.
	human	leukemia	JCRB0118	SKM-1	myelo dysplastic syndrome
	human	leukemia	JCRB0086	TALL-1	leukemia, acute T lymphoblastic
human:liver cancer Top
	human	liver cancer	JCRB0403	HuH-7	Well differentiated human hepato cellular carcinoma cell line.
human:liver, gallbladder Top
	human	liver, gallbladder	IFO50069	Alexander cells	hepatoma, HBs antigen-positive. This cell line is the same cell line as PLF/PRF/5 (other name of PLC/PRF/5).
	human	liver, gallbladder	JCRB1054	Hep G2	Hepatoblastoma-derived (previously thought to be hepatocellular carcinoma-derived) cell line.
	human	liver, gallbladder	JCRB0404	HLE	hepatoma, non-differentiated
	human	liver, gallbladder	JCRB0405	HLF	hepatoma, non-differentiated
	human	liver, gallbladder	JCRB0425	HuCCT1	Human liver bile duct carcinoma cell line.
	human	liver, gallbladder	JCRB0199	huH-1	Human hepatoma cell line.
	human	liver, gallbladder	JCRB0426	HuH28	Human liver, bile duct carcinoma cell line.
	human	liver, gallbladder	JCRB1028	JHH-2	Human hepatocellular carcinoma cell line (Ed.II).
	human	liver, gallbladder	JCRB0435	JHH-4	Human hepatocellular carcinoma cell line.
	human	liver, gallbladder	JCRB1029	JHH-5	Human hepatocellular carcinoma (Ed.I) established from small liver cancer.
	human	liver, gallbladder	JCRB1030	JHH-6	Human hepatocellular carcinoma cell line.
	human	liver, gallbladder	JCRB1031	JHH-7	HBV integrated human hepato cellular carcinoma cell line.
	human	liver, gallbladder	JCRB1551	KKU-055	Human poorly differentiated cholangiocarcinoma cell line established from biliary tract.
	human	liver, gallbladder	JCRB1568	KKU-100	Human poorly differentiated cholangiocarcinoma cell line established from biliary tract.
	human	liver, gallbladder	JCRB1557	KKU-213	Human mixed (papillary and non-papillary) cholangiocarcinoma cell line established from biliary tract.
	human	liver, gallbladder	JCRB1772	KKU-452	Human poorly differentiated cholangiocarcinoma cell line established from biliary tract.
	human	liver, gallbladder	JCRB0160	LI90	Ito (fat-storing) cells, stellate-shaped mesenchymal cells that exist in the space of Disse of the liver and contain many fat droplets in cytoplasm.
	human	liver, gallbladder	JCRB1033	NOZ	Human gallbladder carcinoma cell line.
	human	liver, gallbladder	JCRB0191	OCUG-1	Human gall bladder carcinoma cell line producing TA-4 antigen.
	human	liver, gallbladder	JCRB1032	OZ	Human bile duct cell line established from ascites of the tumor patient who had differentiated adenocarcinoma.
	human	liver, gallbladder	JCRB0406	PLC/PRF/5	hepatoma, HBs antigen-positive
Japan Domestic use only	human	liver, gallbladder	JCRB1501	TYBDC-1	Human bile duct cancer cell line.
Japan Domestic use only	human	liver, gallbladder	JCRB1499	TYGBK-1	Human gall bladder cancer cell line.
Japan Domestic use only	human	liver, gallbladder	JCRB1590	TYGBK-8	Human gall bladder cancer cell line.
human:lung Top
	human	lung	JCRB0815	ABC-1	adenocarcinoma
	human	lung	JCRB9101	CCD-14Br	bronchus, diploid
	human	lung	JCRB0820	EBC-1	squamous cell carcinoma
	human	lung	IFO50089	Flow2000	Normal diploid fibroblasts with limited life span.
	human	lung	JCRB1080.0	HARA	Human lung squamous cell carcinoma with PTHrP expression.
	human	lung	IFO50074	HFL1	Normal diploid fibroblasts with limited life span.
	human	lung	JCRB9054	IMR-90	Normal human fibroblast.
	human	lung	JCRB0519	IMR-90-40	Normal human fibroblast.
	human	lung	JCRB0829	LK-2	squamous cell carcinoma
	human	lung	JCRB0235	Lu-134-A-H	small cell carcinoma, classic type
	human	lung	JCRB0080	LU99	giant cell carcinoma
	human	lung	JCRB9008	MRC-5	fetal lung, normal diploid fibroblast
	human	lung	IFO50073	MRC-5	Normal diploid fibroblasts with limited life span (crisis PDL = 42-46).
	human	lung	JCRB0521	MRC-5-30	fetal lung, normal diploid fibroblast, PDL=about 30
	human	lung	JCRB9060	MRC-9	fetal lung, normal diploid fibroblast
	human	lung	IFO50072	MRC-9	Normal diploid fibroblasts with limited life span (crisis PDL = 44).
	human	lung	JCRB1034	OUS-11	Normal human cell line from lung cancer patient.
	human	lung	JCRB1020	RERF-LC-Ad1	Human lung cancer cell line, adenocarcinoma.
	human	lung	JCRB1021	RERF-LC-Ad2	Human cancer cell line, adenocarcinoma.
	human	lung	JCRB0081	RERF-LC-MS	adenocarcinoma
	human	lung	JCRB0818	SBC-3	small cell carcinoma, oat cell type
	human	lung	JCRB0819	SBC-5	small cell carcinoma, intermediate
	human	lung	JCRB0506.1	SVts-8	Human normal diploid fibroblast cell line transformed with SV40(ts) early gene. Cell culture at 34 C.
	human	lung	JCRB0501	TIG-1-20	fetal lung, normal diploid fibroblast, TIG-1, PDL=about 20
	human	lung	JCRB0502	TIG-1-30	fetal lung, normal diploid fibroblast, TIG-1, PDL=about 30
	human	lung	JCRB0503	TIG-1-40	fetal lung, normal diploid fibroblast, TIG-1, PDL=about 40
	human	lung	JCRB0504	TIG-1-50	fetal lung, normal diploid fibroblast, TIG-1, PDL=about 50
	human	lung	JCRB0505	TIG-1-60	fetal lung, normal diploid fibroblast, TIG-1, PDL=about 60
	human	lung	JCRB0506	TIG-3-20	Normal fibroblast cell line derived from Japanese fetal lung.
	human	lung	JCRB0511	TIG-7-20	fetal lung, normal diploid fibroblast, TIG-7, PDL=about 20
	human	lung	JCRB0103	VMRC-LCP	squamous cell carcinoma
	human	lung	JCRB9042	WI-26 VA4	SV-40 virus transformed human lung cell line.
	human	lung	IFO50075	WI-38	Normal diploid fibroblast with limeted life span. This cell line at around 30 PDL is distributed.
	human	lung	JCRB9057	WI-38 VA13 sub 2 RA	fetal lung, SV40 virus transformed, derivative of WI-38
	human	lung	JCRB0518	WI-38-40	Normal primary cells from lung as well as JCRB0517. Now only the JCRB0518 with PDL 40 is available.
human:lung (cancer) Top
	human	lung (cancer)	JCRB0076	A549	Human adeno carcinoma cell line derived from lung cancer.
	human	lung (cancer)	IFO50153	A549	adenocarcinoma
	human	lung (cancer)	JCRB1080.1	HARA-B	HARA cell (human lung squamouse cell carcinoma) established from bone metastasis in nude mouse.
	human	lung (cancer)	JCRB1552	HARA-B4	HARA cell (human lung squamouse cell carcinoma) established from bone metastasis (4 times selection) in nude mouse.
	human	lung (cancer)	JCRB0138	KHM-3S	small cell carcinoma, HTLV-1gene integration
	human	lung (cancer)	IFO50358	KNS-62	bronchial squamous carcinoma, metastasis to brain
	human	lung (cancer)	JCRB0258	LC-1 sq	squamous cell carcinoma
	human	lung (cancer)	JCRB0169	Lu-134-B	Small cell lung carcinoma cell line established through heterotransplanted tumor.
	human	lung (cancer)	JCRB0079	LU65	Human cell line with giant cell carcinoma of lung.
	human	lung (cancer)	JCRB0054	LU65A	giant cell carcinoma
	human	lung (cancer)	JCRB0055	LU65B	giant cell carcinoma
	human	lung (cancer)	JCRB0056	LU65C	giant cell carcinoma
	human	lung (cancer)	JCRB0044	LU99A	giant cell carcinoma
	human	lung (cancer)	JCRB0057	LU99B	Lung giant cell carcinoma
	human	lung (cancer)	JCRB0058	LU99C	Lung giant cell carcinoma.
	human	lung (cancer)	JCRB1081	MS-1-L	Human lung small cell carcinoma from pleural effusion.
	human	lung (cancer)	JCRB1343	OKa-C-1	Lung cancer cell line producing both G-CSF and PTHrP.
	human	lung (cancer)	JCRB0077	PC-3	adenocarcinoma, intermediately differentiated
	human	lung (cancer)	JCRB0102	RERF-LC-FM	small cell carcinoma, intermediate
	human	lung (cancer)	JCRB0137	RERF-LC-KJ	adenocarcinoma, transplantable to SCID mice and frequently metastasize to lymph nodes
	human	lung (cancer)	JCRB1019	RERF-LC-Sq1	Cell line established from human lung carcinoma tissue.
	human	lung (cancer)	JCRB1053	STC 1	Human small cell lung carcinoma.
	human	lung (cancer)	JCRB0814	VMRC-LCD	adenocarcinoma
human:lung cancer Top
	human	lung cancer	JCRB0170	Lu-135	Human small cell lung carcinoma cell line.
human:lymph node Top
Japan Domestic use only	human	lymph node	JCRB1470	SUm/c	SUm/c was established from floating in the lymph of the thoracic duct of patients with esophageal squamous cell carcinoma.
human:lymphoblastoid Top
	human	lymphoblastoid	JCRB1752	XYFMGG16M	EBV transformed B-cell lymphoblastoid cell line from human XY female.
human:lymphocyte Top
	human	lymphocyte	JCRB9063	WIL2-NS	B lymphocyte line, from patient with hereditary spherocytic anemia, non-immunoglobulin secreting variant
human:lymphocytic Top
	human	lymphocytic	IFO50518	KAI3	EBV-infected NK-like cell line, IL-2 dependent
human:lymphoma Top
	human	lymphoma	JCRB0101	A3/KAW	lymphoma, malignant
	human	lymphoma	JCRB1765	Akata-EBV-N	Epstein-Barr virus (EBV)-negative cell line established from a Japanese patient with Burkitt’s lymphoma.
	human	lymphoma	JCRB9071	Daudi	lymphoma, Burkitt's
	human	lymphoma	JCRB1977	HCF-MLp-N	human B-cell line derived from non-Hodgkin's lymphoma, Primary Central Nervous System Lymphoma, PCNSL
	human	lymphoma	JCRB1347	KML-1	Human B-cell lymphoma cell line.
	human	lymphoma	JCRB4016	WILL3	Human diffuse large B-cell lymphoma cell line with two translocations t(14;18)(q32; q21) and t(8;22)(q24;q11).
human:mammary Top
	human	mammary	JCRB0166	HMC-1-8	A target cell of the T-cell killer clone T(cHMC-1).
	human	mammary	JCRB0134	MCF-7	Human metastatic mammary carcinoma cell line.
	human	mammary	JCRB0628	MRK-nu-1	Human mammary carcinoma cell line.
	human	mammary	JCRB0823	YMB-1	breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1.
	human	mammary	JCRB0825	YMB-1-E	breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1.
human:melanoma Top
	human	melanoma	IFO50276	A2058	malignant melanoma, metastasis to lymph node
	human	melanoma	JCRB0227	C32TG	Human 6TG resistant amelanotic melanoma cell line from skin.
	human	melanoma	JCRB9074	G-361	malignant melanoma, skin
	human	melanoma	IFO50009	G-361	This cell line produces melanin.
	human	melanoma	IFO50321	GAK	Human malignant melanoma cell line with the production of 5-S-cysteinyldopa.
	human	melanoma	JCRB0180	GAK	Human malignant melanoma cell line with the production of 5-S-cysteinyldopa.
	human	melanoma	JCRB1018	HMY-1	Mlignant melanoma cell line.
	human	melanoma	JCRB0066	Mewo	malignant melanoma
	human	melanoma	JCRB1041	SEKI	Human malignant melanoma cell line.
	human	melanoma	JCRB0074	VMRC-MELG	malignant melanoma, colon
human:mesenchymal stem Top
	human	mesenchymal stem	JCRB1154	UE7T-13	Human bone marrow-derived mesenchymal stem cells.
human:mesenchymal stem cell Top
	human	mesenchymal stem cell	JCRB1159	UBE6T-15	Human bone marrow-derived mesenchymal stem cells.
	human	mesenchymal stem cell	JCRB1140	UBE6T-6	Human bone marrow-derived mesenchymal stem cells.
	human	mesenchymal stem cell	JCRB1143	UBE6T-7	Human bone marrow-derived mesenchymal stem cells.
Japan Domestic use only	human	mesenchymal stem cell	JCRB1108	UCB408E6E7-31	Human umbilical cord blood-derived mesenchymal stem cells. Not immortalized cell line (limited life span).
	human	mesenchymal stem cell	JCRB1110	UCB408E6E7TERT-33	Human umbilical cord blood-derived mesenchymal stem cells.
Japan Domestic use only	human	mesenchymal stem cell	JCRB1109	UCB408E7-32	Human umbilical cord blood-derived mesenchymal stem cells. Not immortalized cell line (limited life span)
	human	mesenchymal stem cell	JCRB1107	UCBTERT-21	Human umbilical cord blood-derived mesenchymal stem cells.
Japan Domestic use only	human	mesenchymal stem cell	JCRB1160	UE6E7-16	Human bone marrow-derived mesenchymal stem cells. Not immortalized cell line (limited life span).
	human	mesenchymal stem cell	JCRB1149	UE6E7T-11	Human bone marrow-derived mesenchymal stem cells.
	human	mesenchymal stem cell	JCRB1151	UE6E7T-12	Human bone marrow-derived mesenchymal stem cells.
	human	mesenchymal stem cell	JCRB1133	UE6E7T-2	Human bone marrow-derived mesenchymal stem cells.
	human	mesenchymal stem cell	JCRB1147	UE7T-9	Human bone marrow-derived mesenchymal stem cells.
human:muscular system Top
	human	muscular system	JCRB0525	TIG-2M-30	muscular tissue derived normal diploid fibroblast (not myoblast), PDL=about 30
human:myeloma Top
	human	myeloma	JCRB0133	KHM-1B	myeloma, multiple, with hyperamylasemia.
	human	myeloma	JCRB1179	KMS-11	human myeloma cell line.
	human	myeloma	JCRB1642	KMS-11/BTZ	bortezomib-resistant multiple myeloma cell line.
	human	myeloma	JCRB0429	KMS-12-BM	myeloma, late stage of B-cell differentiation
	human	myeloma	JCRB0430	KMS-12-PE	myeloma, late stage of B-cell differentiation
	human	myeloma	JCRB1196	KMS-20	human myeloma cell line.
	human	myeloma	JCRB1185	KMS-21BM	human myeloma cell line.
	human	myeloma	JCRB1187	KMS-26	human myeloma cell line.
	human	myeloma	JCRB1188	KMS-27	human myeloma cell line.
	human	myeloma	JCRB1192	KMS-28BM	human myeloma cell line.
	human	myeloma	JCRB1191	KMS-28PE	Human myeloma cell line.
	human	myeloma	JCRB1391	KMS-33	human myeloma cell line.
	human	myeloma	JCRB1195	KMS-34	human myeloma cell line.
	human	myeloma	JCRB4021	KMS21	human myeloma cell line. Deposited together with KMS21R and KMS21RF, as their control cell. If you need KMS-21 only, please choose JCRB1185 KMS-21BM.
	human	myeloma	JCRB1820	MOLP-2	Multiple myeloma-derived cell line. IL-6 receptor(+), CD28(+), CD33(+), IgD ramda(+) (Growth is extremely slow, DT = 1 week.)
human:nasal septum Top
	human	nasal septum	JCRB9058	RPMI 2650	quasi-diploid squamous carcinoma
human:neural Top
	human	neural	JCRB0228	A-172	glioblastoma
	human	neural	IFO50361	B2-17	astrocytoma, thymidine kinase-deficient mutant of U-251 MG cells
	human	neural	IFO50289	Becker	astrocytoma, GFAP-negative
	human	neural	JCRB0068	Flow3000	normal fibroblast
	human	neural	IFO50489	GB-1	glioma, GFAP, vimentin and fibronectin-positive
	human	neural	JCRB0612	GOTO	neuroblastoma, adrenal gland
	human	neural	JCRB9050	IMR-32	Human neuroblastoma cell line.
	human	neural	IFO50283	IMR-32	Human nueroblastoma cell line.
	human	neural	IFO50434	KALS-1	GFAP is weakly positive.
	human	neural	JCRB0236	KG-1-C	mixed glioma, GFAP-negative, S-100-positive (growth is very slow).
	human	neural	IFO50435	KINGS-1	astrocytoma, anaplastic, S-100, vimentin, CD13 and HNK-1-positive, weakly GFAP positive.
	human	neural	IFO50357	KNS-60	glioma, GFAP, S-100 and NSE-negative
	human	neural	IFO50359	KNS-81	glioma, GFAP and S-100-positive, NSE-negative
	human	neural	IFO50444	KNS-81-FD	GFAP-positive human glioma cell line.
	human	neural	IFO50432	KP-N-RT-BM-1	neuroblastoma, from bone marrow, neuronal and Schwannian differentiation
	human	neural	IFO50433	KP-N-SI9s	Alpha-smooth muscle actin and desmin-positive. Some S-type cells may have the potential to differentiate into cells with smooth muscle phonotypes.
	human	neural	IFO50431	KP-N-YN	Alpha smooth muscle actin-positive.
	human	neural	IFO50436	KS-1	glioblastoma
	human	neural	JCRB0154	NB(TU)1-10	Humn neuroblastoma(stageIII) cell line from abdominal tumor with N-myc aberration.
	human	neural	JCRB0621	NB-1	Human neuroblastoma cell line differentiate in vitro by cAMP.
	human	neural	IFO50295	NB-1	neuroblastoma
	human	neural	JCRB1305	NCC-RbC-39	Huaman retinoblastoma cell line. The growth is extremely slow.
	human	neural	JCRB1182	NCC-RbC-51	Human retinoblastoma cell line. The growth is very slow.
	human	neural	JCRB1200	NCC-RbC-53	Human retinoblastoma cell line. The growth is extremely slow.
	human	neural	JCRB1183	NCC-RbC-54	Human retinoblastoma cell line. The growth is extremely slow.
	human	neural	JCRB1212	NCC-RbC-56	Human retinoblastoma cell line. The growth is extremely slow.
	human	neural	JCRB1190	NCC-RbC-57	Human retinoblastoma cell line.
	human	neural	JCRB1326	NCC-RbC-60	Huaman retinoblastoma cell line. The growth is very slow.
	human	neural	JCRB1214	NCC-RbC-67	Human retinoblastoma cell line. The growth is extremely slow.
	human	neural	JCRB1221	NCC-RbC-92	Huaman retinoblastoma cell line. The growth is extremely slow.
	human	neural	JCRB1223	NCC-RbC-T1	Human retinoblastoma cell line. The growth is very slow.
	human	neural	JCRB0833	NH-12	neuroblastoma, adrenal gland
	human	neural	JCRB0832	NH-6	neuroblastoma, adrenal gland, opsomyoclonus, truncal ataxia
	human	neural	IFO50467	NMC-G1	glioma, FGF-9-producing
	human	neural	IFO50368	no.10	Human anaplastic glioma cell line derived from brain.
	human	neural	IFO50369	no.11	glioma, anaplastic, GFAP-positive
	human	neural	JCRB1566	NP 2	Human cell line derived from human glioma.
	human	neural	JCRB1567	NP 3	Human cell line derived from human glioma.
	human	neural	JCRB1608	NP 8	Human cell line derived from human glioma.
	human	neural	JCRB1606	Onda 10	Human cell line derived from human glioma.
	human	neural	JCRB1605	Onda 11	Human cell line derived from human glioma.
	human	neural	JCRB1575	Onda 7	Human cell line derived from human glioma.
	human	neural	JCRB1578	Onda 8	Human cell line derived from human glioma.
	human	neural	JCRB1576	Onda 9	Human cell line derived from human glioma.
	human	neural	JCRB1583	Onda 9R	Human cell line derived from human recurred glioma.
	human	neural	JCRB1607	Onda 9R-B12	Human clonal cell line derived from human recurred glioma.
	human	neural	IFO50355	ONS-76	medulloblastoma
	human	neural	JCRB1340	RS-2	metastatic primitive neuroectodermal tumor cell line (derived from metastatic tumor).
	human	neural	JCRB0106	SCCH-26	Human neuroblastoma cell line.
	human	neural	IFO50286	SF126	glioblastoma multiforme, GFAP-negative
	human	neural	JCRB9041	T98G	Human glioblastoma multiforma tumor.
	human	neural	IFO50303	T98G	glioblastoma, multiforme
	human	neural	JCRB0139	TASK1	Human cell line with primitive neuroectodermal tumor (Askin's tumor).
	human	neural	JCRB0618	TGW	neuroblastoma, adrenal gland
	human	neural	JCRB0618.1	TGW.P3	Serum free cell culture of the human neuroblastoma cell line, TGW.
	human	neural	IFO50288	U-251 MG	astrocytoma, GFAP-positive
	human	neural	IFO50285	U-251 MG (KO)	Subline of U-251 MG (IFO 50288) with epithelial morphology.
	human	neural	IFO50493	YH-13	glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-resistant
	human	neural	JCRB0746	YKG-1	glioblastoma
human:neuroblastoma cell line Top
	human	neuroblastoma cell line	JCRB0612.1	GOTO.P3	Serum free cell culture of neuroblastoma cell line.
human:oral Top
	human	oral	JCRB0625	Ca9-22	squamous carcinoma, gingiva
	human	oral	JCRB9095	HEPM	embryonic palatal mesenchyme, limited life span
	human	oral	JCRB0831	HO-1-N-1	squamous carcinoma, buccal mucosa
	human	oral	JCRB1354	HSC-3-M3	Highly metastatic cell line to lymph node in human oral squamous cell carcinoma derived from the HSC-3.
	human	oral	JCRB9103	KD	fibroblast, lip
	human	oral	JCRB0194	KON	Human squamous carcinoma cell line from oral floor.
	human	oral	JCRB0126.1	KOSC-2 cl3-43	Human tumor cells derived from oral cancer at stage III. The cells were originally cross contaminated with mouse cells but the mouse cells were eliminated in the JCRB cell bank and the cl3-43 subclone ID was applied to the cell name.
	human	oral	JCRB0198	OSC-19	Human squamous cell carcinoma cell line from tongue tumor with serum free cell culture.
	human	oral	JCRB0197	OSC-20	Human squamous cell carcinoma cell line from tongue metastasized to neck lymph node(left), which was cultured with serum free condition.
	human	oral	JCRB0260	SAS	squamous carcinoma, tongue
	human	oral	JCRB1027	SAT	Human squamous cell carcinoma with non-metastatic cell line derived from oral cavity.
	human	oral	JCRB9118	SCC-4	squamous carcinoma, tongue
	human	oral	JCRB1039	SKN-3	Human oral squamous carcinoma established from xenotransplantation in mice.
human:oral cancer Top
	human	oral cancer	JCRB0828	HO-1-u-1	squamous carcinoma, mouth floor
	human	oral cancer	JCRB0622	HSC-2	squamous carcinoma, mouth
	human	oral cancer	JCRB0624	HSC-4	Human squamous carcinoma cell line from tongue.
human:ovarian cancer Top
	human	ovarian cancer	JCRB1729	RMG-V	Human ovarian clear cell adenocarcinoma cell line.
human:ovary Top
	human	ovary	JCRB1359	HAC-2	Human ovary cancer cell line derived from mesonephros.
	human	ovary	JCRB1539	HAC-2	Human ovary cancer cell line derived from mesonephros.
	human	ovary	JCRB0098	KURAMOCHI	undifferentiated carcinoma, ascites
	human	ovary	JCRB0240	MCAS	mucinous cystadenocarcinoma
	human	ovary	JCRB1308	NCC-OvC-K119	Huaman ovarian carcinoma cell line.
	human	ovary	JCRB1043	OVISE	Human cell line derived from ovarian tumor.
	human	ovary	JCRB1044	OVKATE	Human cell line derived from ovarian tumor.
	human	ovary	JCRB1045	OVMANA	Human cell line derived from ovarian tumour.
	human	ovary	JCRB1049	OVMIU	Human cell line derived from ovarian tumour.
	human	ovary	JCRB1050	OVMIU-II	Human cell line derived from ovarian tumour.
	human	ovary	JCRB1046	OVSAHO	Human cell line derived from ovarian tumour.
	human	ovary	JCRB1047	OVSAYO	Human cell line derived from ovarian tumour.
	human	ovary	JCRB1048	OVTOKO	Human cell line derived from ovarian tumour.
	human	ovary	IFO50317	RKN	leiomyosarcoma
	human	ovary	JCRB0176	RKN	Human tumor cell line from myoma ovarii.
	human	ovary	IFO50315	RMG-I	clear cell carcinoma
	human	ovary	JCRB0172	RMG-I	Human tumor cell line from ovarian mesonephroid adenocarcinoma.
	human	ovary	JCRB0172.1	RMG-II	Human ovarian mesonephroid adenocarcinoma cell line.
	human	ovary	IFO50320	RMUG-S	mucinous cystadenocarcinoma
	human	ovary	JCRB0234.0	TYK-nu	undifferentiated carcinoma
	human	ovary	JCRB0234.1	TYK-nu.CP-r	Human cell line derived from ovary with undifferentiated carcinoma.
human:pancreas Top
	human	pancreas	JCRB4026	KE-66	Poorly differentiated adenocarcinoma with giant cells
Japan Domestic use only	human	pancreas	JCRB1427	KMP2	Human moderately differentiated pancreatic adenocarcinoma cell line established from liver metastasis.
Japan Domestic use only	human	pancreas	JCRB1464	KMP5	Human moderately differentiated adenocarcinoma cell line established from liver metastasis.
Japan Domestic use only	human	pancreas	JCRB1429	KMP7	Human pancreatic adenocarcinoma cell line established from liver metastasis.
Japan Domestic use only	human	pancreas	JCRB1461	KMP8	Human moderately differentiated pancreatic adenocarcinoma cell line established from liver metastasis.
	human	pancreas	JCRB0181	KP-2	Human pancreatic tumor cell line.
	human	pancreas	JCRB0178.0	KP-3	A metastasis of adenosquamous carcinoma of the human pancreatic duct.
	human	pancreas	JCRB0178.1	KP-3L	Human tumor cell line obtained from metastasis of adenosquamous carcinoma of the pancreatic duct.
	human	pancreas	JCRB0182	KP-4	Human tumor cell line secreting parathyroid hormone-related peptide (PTHrP) established from ascites metastasis of pancreatic tumor.
	human	pancreas	JCRB0070	MIA PaCa-2	pancreatic cancer
	human	pancreas	JCRB0183	QGP-1	Carcinoembryonic antigen (CEA)-producing human pancreatic ilet cell carcinoma cell line.
	human	pancreas	JCRB1882	Sui65	Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from peritoneal metastasis.
	human	pancreas	JCRB1919	Sui69	Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from pancreas adenocarcinoma. (The life span of this cell line is limited.)
	human	pancreas	JCRB1931	Sui74	Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from pancreas adenocarcinoma.
	human	pancreas	JCRB1929	Sui77	Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from liver metastasis.
	human	pancreas	JCRB1094	SUIT-2	Human pancreatic cancer cell line established from liver metastasis.
	human	pancreas	JCRB1921	TCC-Pan2	Pancreatic ductal adenocarcinoma. Cell line established from ascites.
Japan Domestic use only	human	pancreas	JCRB1500	TYPK-1	Human pancreas adenocarcinoma cell line.
human:placenta Top
	human	placenta	JCRB9111	BeWo	Human placenta derived cell line.
human:pleura Top
	human	pleura	JCRB1913	Me1Tu	Transplanted cell line of malignant pleural mesothelioma TCC-MESO-1 into SCID mice.
	human	pleura	JCRB1930	Me2Tu	Transplanted cell line of malignant pleural mesothelioma TCC-MESO-2 into SCID mice.
	human	pleura	JCRB1937	Me3Tu	Transplanted cell line of malignant pleural mesothelioma TCC-MESO-3 into SCID mice.
	human	pleura	JCRB1894	TCC-MESO-1	Cell line of malignant pleural mesothelioma. TCC-MESO-2 established from same individual.
	human	pleura	JCRB1898	TCC-MESO-2	Cell line of malignant pleural mesothelioma. TCC-MESO-1 established from same individual.
	human	pleura	JCRB1909	TCC-MESO-3	Cell line of malignant pleural mesothelioma.
human:prostate gland Top
	human	prostate gland	JCRB9110	PC-3	adenocarcinoma
human:rectum Top
	human	rectum	JCRB0207	CaR-1	adenocarcinoma
	human	rectum	JCRB0256	RCM-1	adenocarcinoma, well differentiated
	human	rectum	JCRB9115	SW837	adenocarcinoma
	human	rectum	JCRB1986	UCCA-24	Derived from colorectal cancer with ulcerative colitis. Isolated as poorly differentiated adenocarcinoma by cloning.
	human	rectum	JCRB1997	UCCA-25	Derived from colorectal cancer with ulcerative colitis. Isolated as adenosquamous carcinoma of the adenomas by cloning.
human:sarcoma Top
	human	sarcoma	IFO50107	G-292 clone A141B1	osteosarcoma
	human	sarcoma	IFO50106	HOS	osteosarcoma
	human	sarcoma	JCRB9113	HT-1080	Human sarcoma cell line with activated N-ras oncogne.
	human	sarcoma	IFO50354	HT-1080	fibrosarcoma, acetabulum
	human	sarcoma	JCRB0413	HuO-3N1	osteosarcoma, ilium
	human	sarcoma	JCRB0427	HuO9	A cell line established from a human osteosarcoma transplanted into athymic nude mice after fifth passages. The cell line expressed 1,25(OH)2D3-responsive alikaline phosphatase and produced tumors in the dorsum of nude mice.
	human	sarcoma	JCRB0428	HuO9N2	osteosarcoma
	human	sarcoma	JCRB1648	ICH-ERMS-1	Human cell derived from anaplastic embryonal rhabdomyosarcoma.
	human	sarcoma	JCRB0200	KMLS-1	liposarcoma
	human	sarcoma	JCRB0627	KYM-1	Human rhabdomyosarcoma cell line derived from neck tumor.
	human	sarcoma	IFO50108	MG-63	osteosarcoma
Japan Domestic use only	human	sarcoma	JCRB1507	NMFH-1	Human retroperitoneal tumor cell line.
	human	sarcoma	JCRB0614	NY	osteosarcoma, femur
	human	sarcoma	IFO50488	OUMS-27	chondrosarcoma, type 1 ,2 and 3 collagens; type 9 and 11 collagen mRNA; proteoglycan-producing
	human	sarcoma	JCRB1806	PIS-1	Human pulmonary intimal sarcoma
	human	sarcoma	JCRB9072	RD	rhabdomyosarcoma
	human	sarcoma	JCRB0108	SCCH-196	Human small round cell sarcoma.
Japan Domestic use only	human	sarcoma	JCRB1521	TYLMS-1	Human leiomyosarcoma cell lineestablised from retroperitopneal tumor.
human:skin Top
	human	skin	IFO50418	ASF-4-1	Normal diploid (46, XY) fibroblast with limited life span. The ASF-4-1 and the ASF-4-2 lines were established from skins of the same donor at different ages. This cell line was taken from the donor at 36 years and 2 month-old
	human	skin	IFO50419	ASF-4-2	Normal diploid (46, XY) fibroblast with limited life span. The ASF-4-1 and ASF-4-2 lines were established from skins of the same donor at different ages. This cell line was taken from the donor at 47 years and 6 month-old.
	human	skin	JCRB1431	ASF-4-3L	Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages.
	human	skin	JCRB1441	ASF-4-4L1	Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages.
	human	skin	JCRB1442	ASF-4-4L2	Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages.
	human	skin	JCRB1705	ASF-4-5L1	Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages.
	human	skin	JCRB1703	ASF-4-5L2	Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages.
	human	skin	JCRB1709	ASF-4-5R1	Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages.
	human	skin	JCRB9078	De Gin	osteoporosis, skin
	human	skin	JCRB9104	Detroit 510	Human skin, galactosemia cell line.
	human	skin	JCRB9102	Detroit 525	Turner's syndrome, skin
	human	skin	JCRB9044	Detroit 532	Fibroblast line from Down's syndrome patient.
	human	skin	JCRB9045	Detroit 539	Down's syndrome, skin
	human	skin	IFO50079	Flow7000	Normal diploid fibroblasts with limited life span.
	human	skin	JCRB1008	HFb16d	Normal human fibroblast cell line derived from foreskin which was transfected by the HPV16 DNA. No teromerase activity.
	human	skin	JCRB1017	HKA-1	A cell line derived from a keratoacanthoma of human skin, grow in a monolayer with anaplastic feature.
	human	skin	IFO50350	Hs68	Normal diploid fibroblasts with limited life span.
	human	skin	JCRB1015	HSC-1	A cell line of a squamous cell carcinoma of human skin.
	human	skin	JCRB1016	HSC-5	A cell line derived from human skin squamous cell carcinoma having anaplastic epithelioid features.
	human	skin	JCRB0072	MiTen	Human cell line from Lesch-Nyhan syndrome.
	human	skin	JCRB0141	PHK16-0b	Normal keratinocyte cells immortalized with HPV16 virus genome and the growth is dependent to EGF. More than 95% of cells are diploid.
	human	skin	JCRB1093	PSVK1	Human normal keratinocyte prepared from human foreskin that was immortalized by the infection of the pSV40 ori-(minus) DNA.
	human	skin	JCRB9079	Ran Nor	osteoporosis, skin
	human	skin	JCRB0075	SF-TY	normal fibroblast
	human	skin	JCRB0526	TIG-101	Normal human diploid cell from skin
	human	skin	JCRB0527	TIG-102	Normal human skin fibroblast cell line.
	human	skin	JCRB0528	TIG-103	skin, normal diploid fibroblast
	human	skin	JCRB0532	TIG-107	skin, normal diploid fibroblast
	human	skin	JCRB0537	TIG-108	skin, normal diploid fibroblast
	human	skin	JCRB0538	TIG-109	Normal diploid human skin cells.
	human	skin	JCRB0543	TIG-110	Normal diploid fibroblast from human skin with limited lifespan.
	human	skin	JCRB0541	TIG-111	Normal diploid fibroblast from human skin with limited lifespan.
	human	skin	JCRB0533	TIG-112	skin, normal diploid fibroblast
	human	skin	JCRB0539	TIG-113	Human normal fibroblast from skin.
	human	skin	JCRB0534	TIG-114	skin, normal diploid fibroblast
	human	skin	JCRB0535	TIG-118	skin, normal diploid fibroblast
	human	skin	JCRB0540	TIG-119	Normal human diploid cell from skin.
	human	skin	JCRB0542	TIG-120	Normal diploid fibroblast from human skin with limited lifespan.
	human	skin	JCRB0536	TIG-121	skin, normal diploid fibroblast
	human	skin	JCRB0544	TIG-3S	Normal diploid fibroblast from human male skin with limited life span.
human:small intestine Top
	human	small intestine	JCRB9076	FHs 74 Int	Human fetal small intestine cells (not the intestinal epithelial cells). The growth is very slow.
	human	small intestine	JCRB4050	SiCry-15X	Small bowel adenocarcinoma cell line using patient‑derived xenografts, which produces CEA and CA19‑9
human:stomach Top
	human	stomach	JCRB1886	39As8	Peritoneal disseminated metastatic cell line established from signet ring cell gastric carcinoma (HSC-39).
	human	stomach	JCRB1949	60As6	Peritoneal disseminated metastatic cell line established from signet ring cell gastric carcinoma (HSC-60).
	human	stomach	JCRB1950	85As2	Peritoneal disseminated metastatic cell line established from gastric cancer cell line (MKN45cL85). Cachexia-inducing cell line.
	human	stomach	JCRB0061	AZ-521	Reported as Human gastric cancer cell line. The STR DNA analysis pattern of AZ-521 revealed to be identical to that of other cell line derived from human duodenum carcinoma, HuTu 80 in ATCC (registry number, HTB-40)
	human	stomach	JCRB1074	FU97	Human stomach cancer cell line with AFP production.
	human	stomach	JCRB1956	HSC-39 PF	Cell line that can be cultured only with HamF12/DMEM (protein free). Culture start at thawing must with 2% FBS.
	human	stomach	JCRB1954	HSC-39R10C	HSC-39-derivative. TGF-β resistant subclone mutated by MNU (N-Methyl-N-nitrosourea).
	human	stomach	JCRB1075.0	IM95	Human gastric cancer cell line.
	human	stomach	JCRB1075.1	IM95m	Human gastric cancer cell line.
	human	stomach	JCRB0611	KATOIII	signet ring cell carcinoma
	human	stomach	JCRB0252	MKN1	adenosquamous carcinoma
Human:stomach Top
	Human	stomach	JCRB1939	MKN45cL85	Subclone of MKN45 (Human Gastric Cancer) cell line. Cachexia-inducing cell line.
	human	stomach	JCRB1025	MKN7	tubular adenocarcinoma, well differentiated
	human	stomach	JCRB0255	MKN74	Human cell line derived from stomach cancer.
	human	stomach	JCRB1228	NCC-StC-K140	Human stomach carcinoma cell line.
	human	stomach	JCRB0821	NUGC-2	adenocarcinoma, poorly differentiated
	human	stomach	JCRB0822	NUGC-3	adenocarcinoma, poorly differentiated
	human	stomach	JCRB0834	NUGC-4	adenocarcinoma, poorly differentiated, signet ring cell carcinoma
	human	stomach	JCRB0192	OCUM-1	Human gastric cancer cell line from poorly differentiated adenocarcinoma.
	human	stomach	JCRB1009	RERF-GC-1B	Human gastric cancer cell line established from a metastatic tissue of pyloric lymph nodes.
	human	stomach	JCRB0251	SCH	choriocarcinoma arising at stomach from male patient
	human	stomach	JCRB1944	SH101-P4	Subclone of SH101 (Human Gastric Cancer) cell line. Well differenciated adenocarcinoma.
	human	stomach	JCRB0124	Takigawa	gastric carcinoma, proliferates very slowly (D.T.=2 weeks).
	human	stomach	JCRB1941	TU-KatoIII	Cell line isolated as 100% tumor-forming cells after tumor formation in immunodeficient mice (NOD Scid→Scid→nu/nu).
Japan Domestic use only	human	stomach	JCRB1522	YS-1	Human primmary cell line established from stomach (tumor infiltrating fibroblast).
human:stomach cancer Top
	human	stomach cancer	JCRB1864	HSC-39	Human signet ring cell gastric carcinoma cell line establised in vitro from ascites.
	human	stomach cancer	JCRB0254	MKN45	adenocarcinoma, poorly differentiated
human:teratocarcinoma Top
	human	teratocarcinoma	JCRB1005	NCC-IT-A3	Human teratocarcinoma cell line from anterior mediastinum.
	human	teratocarcinoma	JCRB9061	PA-1	Human ovarian teratocarcinoma.
	human	teratocarcinoma	JCRB1052	PA-1/6TG-r	Human teratocarcinoma cell line PA-1 with 6TG resistance.
human:testis Top
	human	testis	JCRB0613	ITO-II	Human testicular tumor cell line.
	human	testis	JCRB1166	NCR-G1	Human yolk sac tumor (testicular tumor)
	human	testis	JCRB1167	NCR-G2	Complex type germ cell tumor of human testis origin.
	human	testis	JCRB1168	NCR-G3	Complex type germ cell tumor of human testis origin.
	human	testis	JCRB1175	NCR-G4	Complex type germ cell tumor of human testis origin.
	human	testis	JCRB0162	NEC14	testicular germ cell tumor
	human	testis	JCRB0250	NEC8	testicular germ cell tumor
human:thymus Top
	human	thymus	JCRB1330	Ty-82	Thymic carcinoma cell line.
human:thyroid Top
	human	thyroid	JCRB0824	8305C	Human undifferentiated thyroid carcinoma with C:G->T:A mutation at codon 273 of p53 gene.
	human	thyroid	JCRB0826	8505C	thyroid carcinoma, undifferentiated
	human	thyroid	JCRB1073	ASH-3	Tumor cell line with multidrug registance obtained from rapidly growing cervical tumor(neck) diagnosed as an anaplastic thyroid carcinoma.
	human	thyroid	JCRB0164	HTC/C3	Human thyroid carcinoma cell line.
	human	thyroid	JCRB1079	IHH-4	Human papillary thyroid carcinoma cell line metastased to lymphnode. STR-PCR analysis showed the same pattern with the cell line TMH-1.
	human	thyroid	JCRB0148	KHM-5M	Undifferentiated human thyroid cell line producing interl eukin 8.
	human	thyroid	JCRB1066	KMH-2	Human anaplasitc thyroid carcinoma cell line with multidrug resistance, derived from a left cervical tumor with a sligt leukocytosis.
	human	thyroid	JCRB1891	OCUT-1C	human anaplastic thyroid cancer cell line
	human	thyroid	JCRB1892	OCUT-3	human anaplastic thyroid cancer cell line
	human	thyroid	JCRB0239	TCO-1	non differentiated cancer
	human	thyroid	JCRB1078	TMH-1	Human adherent monolayer cell line with multidrug resistance obtained from a benign goiter and chronic thyroiditis.
human:thyroid cancer Top
	human	thyroid cancer	JCRB1897	OCUT-1F	human anaplastic thyroid cancer cell line
	human	thyroid cancer	JCRB1857	OCUT-4	human anaplastic thyroid cancer cell line
	human	thyroid cancer	JCRB1872	OCUT-6	human anaplastic thyroid cancer cell line
human:tongue Top
	human	tongue	JCRB0623	HSC-3	Human oral squamous carcinoma cell line with high metastatic potential.
human:uterine cervix Top
	human	uterine cervix	IFO50323	BOKU	cervical squamous cell carcinoma
	human	uterine cervix	IFO50007	Ca Ski	Human epidermoid cervical cancer cell line.
	human	uterine cervix	JCRB1153	HCA-1	Human endocervical adenocarcinoma cell line.
	human	uterine cervix	JCRB1203	HCS-2	Human squamous cell carcinoma from uterine cervix.
	human	uterine cervix	JCRB1205	HCSC-1	Human endocervical carcinoma cell line.
	human	uterine cervix	JCRB9004	HeLa	The first aneuploid, epitherial-like cell line(Feb. 1951) from human tissue and maintained continuously by serial cell culture.
	human	uterine cervix	JCRB9086	HeLa 229	Subline of the HeLa cell.
	human	uterine cervix	JCRB0213	HeLa AG	epitheloid carcinoma, 8-azaguanine-resistant
	human	uterine cervix	JCRB9010	HeLa S3	cervical epitheloid carcinoma, adaptable to a suspension culture
	human	uterine cervix	IFO50011	HeLa S3	This cell line is a clone derived from the HeLa cells. Adaptable to suspension culture.
	human	uterine cervix	JCRB0713	HeLa S3 (sc)	HeLa derivative, can grow in suspension culture
	human	uterine cervix	JCRB0214	HeLa TG	epitheloid carcinoma, 6-thioguanine-resistant
	human	uterine cervix	JCRB0215	HeLa TG Cap	epitheloid carcinoma, 6-thioguanine, chloramphenicol-resistant
	human	uterine cervix	JCRB0649	HeLa.P3	Serum free cell line of the famous HeLa.
	human	uterine cervix	JCRB0606	HeLa.P3(S)	HeLa cell derived, can grow in a serum-free medium
	human	uterine cervix	JCRB0810	ME-180	cervical carcinoama
	human	uterine cervix	JCRB0174.0	NCC16-P11	Normal human endo-cervical columner cells immortalized by HPV16 virus genome and no tumor formation observed in nude mice. Growth is not dependent to EGF.
	human	uterine cervix	JCRB1090	NCE 16IIA	HPV16 transformed noraml cells derived from human cervix.
	human	uterine cervix	JCRB1092	NCE SVIA6	SV40 transformed human keratinocyte cell line.
	human	uterine cervix	JCRB1091	NCE SVIIA3	SV40 transformed keratinocyte cells derived from human cervix.
	human	uterine cervix	JCRB0140	NCE16	Normal ecto-cervical keratinocyte cells immortalized by HPV16 virus genome. Growth of this cell line is dependent to EGF.
	human	uterine cervix	IFO50308	SKG-I	cervical epidermoid carcinoma
	human	uterine cervix	IFO50309	SKG-II	cervical epidermoid carcinoma, large cell, non-keratinizing type
	human	uterine cervix	JCRB0232	SKG-IIIa	cervical epidermoid carcinoma, clear cell type
	human	uterine cervix	IFO50310	SKG-IIIa	cervical epidermoid carcinoma, clear cell type
	human	uterine cervix	IFO50311	SKG-IIIb	cervical epidermoid carcinoma, large cell, non-keratinizing type
	human	uterine cervix	JCRB0232.1	SKG-IIIb	Human tumor cell line with non-keratinizing type squamous cell carcinoma from cervical tumor. Temperature sensitive growth was observed.
human:uterus Top
	human	uterus	JCRB1601	EMTOKA	Human cell line derived from uterine carcinosarcoma.
	human	uterus	JCRB1201	GCH-nu-YS	Human gestational choriocarcinoma cell line.
	human	uterus	JCRB0042	HEC-1	Human endometrial adenocarcimona cell line. (HEC-1-B).
	human	uterus	JCRB1117	HEC-1-A	Human endometroid adenocarcinoma, G2 from Japanese female.
	human	uterus	JCRB1193	HEC-1-B	Endometrioid adenocarcinoma (G2) from human uterus body.
	human	uterus	JCRB1123	HEC-108	Human tumor cell line from uterine endometrium.
	human	uterus	JCRB1124	HEC-116	Human tumor cell line from endometrioid adenocarcinoma G2.
	human	uterus	JCRB1122	HEC-151	Human endometrioid adenocarcinoma, G2.
	human	uterus	JCRB1141	HEC-251	Human endometrial carcinoma from uterus body.
	human	uterus	JCRB1142	HEC-265	Human endometrioid adenocarcinoma, G1 from uterus.
	human	uterus	JCRB1145	HEC-50B	Human endometrioid adenocarcinoma (G3) from japanese patient.
	human	uterus	JCRB1120	HEC-59	Human tumor cell line from endometrioid adenocarcinoma G2.
	human	uterus	JCRB1118	HEC-6	Human endometrial adenocarcinoma cell line.
	human	uterus	JCRB1121	HEC-88nu	endometrial adenocarcinoma
	human	uterus	IFO50322	NJG	gestational uterine choriocarcinoma
	human	uterus	IFO50314	SKN	leiomyosarcoma
	human	uterus	IFO50312	SNG-II	endometrial adenocarcinoma
	human	uterus	IFO50313	SNG-M	endometrial adenocarcinoma
	human	uterus	JCRB0179	SNG-M	Intermedicately differentiated human adenocarcinoma cell line.
human:uterus cancer Top
	human	uterus cancer	JCRB1505	Ishikawa 3-H-12	Estrogen receptor (ER), progesterone receptor (PR) expressing cell line.
	human	uterus cancer	JCRB0173	SKN	Human tumor cell line from uterus leiomyosarcoma.
human:vascular system Top
	human	vascular system	IFO50271	HUV-EC-C	Normal endothelial cells with limited life span. For cultivation, endothelial cell growth supplement can be substituted by ca 10 ng/ml basic FGF.
Japan Domestic use only	human	vascular system	JCRB1520	TYHPC-1	Human hemangiopericytoma cell line established from liver metastasis.
human chromosome-introduced:human monochromosomal hybrid panel Top
	human chromosome-introduced	human monochromosomal hybrid panel	JCRB2209	CHO(His9)	contains human chromosome # 9 (MTA with Tottori Univ. is required.)
Indian Muntjak:skin Top
	Indian Muntjak	skin	JCRB9100	Indian Muntjac	Indian muntjak cell line, a primitive deer.
Indian Muntjak:thymus Top
	Indian Muntjak	thymus	JCRB0609.1	Mm2T.P3	Mutntjac thymus cell cell line.
	Indian Muntjak	thymus	JCRB0650.1	Mm2T12.P3	Serum free subline from Mm2T cells.
marsupial (potoroo, rat kangaroo):kidney Top
	marsupial (potoroo, rat kangaroo)	kidney	JCRB9039	Pt K1	kidney
	marsupial (potoroo, rat kangaroo)	kidney	JCRB0007	Pt K2	DNA replication study
	marsupial (potoroo, rat kangaroo)	kidney	IFO50012	Pt K2	kidney, epithelial-like
	marsupial (potoroo, rat kangaroo)	kidney	JCRB9052	Pt K2 (NBL-5)	kidney
mink:lung Top
	mink	lung	JCRB9128	Mv 1 Lu	useful for focus forming assays of murine and feline sarcoma virus
monkey, African green:kidney Top
Japan Domestic use only	monkey, African green	kidney	JCRB9126	BS-C-1	Kidney cell line of the african green monkey.
Japan Domestic use only	monkey, African green	kidney	IFO50413	BS-C-1	suitable host for transfection experiments of SV40 vectors
Japan Domestic use only	monkey, African green	kidney	JCRB9082	COS-1	SV40 transformed African green monkey kidney
Japan Domestic use only	monkey, African green	kidney	JCRB9127	COS-7	African green monkey cell line producing T antigen of SV40.
Japan Domestic use only	monkey, African green	kidney	IFO50068	COS-7	This line is a transformant derived from CV-1 cell by origin gene-defective mutant of SV40 virus. This cell line is useful for transfection of expression plasmid.
Japan Domestic use only	monkey, African green	kidney	JCRB9049	CV-1	kidney, highly susceptible to SV40 infection
Japan Domestic use only	monkey, African green	kidney	JCRB0111	VERO	African Green Monkey kidney normal cell line.
Japan Domestic use only	monkey, African green	kidney	JCRB9013	VERO	normal, contact inhibited
Japan Domestic use only	monkey, African green	kidney	IFO50471	Vero	useful to assay mycoplasmas
Japan Domestic use only	monkey, African green	kidney	JCRB9007	VERO 76	normal, contact inhibited, lower saturation density than the original Vero
Japan Domestic use only	monkey, African green	kidney	IFO50410	VERO 76	Subclone of the VERO cells.
monkey, Cynomolgus:hemo-lymphocytic Top
Japan Domestic use only	monkey, Cynomolgus	hemo-lymphocytic	JCRB1646	HSC-3	Peripheral blood lymphocyte cell line of cynomolgus monkey (immortalized by Herpesvirus saimiri).
Japan Domestic use only	monkey, Cynomolgus	hemo-lymphocytic	JCRB1652	HSC-4	Peripheral blood lymphocyte cell line of cynomolgus monkey (immortalized by Herpesvirus saimiri).
Japan Domestic use only	monkey, Cynomolgus	hemo-lymphocytic	JCRB1164	HSC-F	T-cell line (fetal spleen-derived lymphocytes) of cynomolgus monkey.
monkey, Cynomolgus:kidney Top
Japan Domestic use only	monkey, Cynomolgus	kidney	JCRB0607.1	MK.P3	Serum free cell culture of the MK(monkey kidney, JTC-12) cell.
Japan Domestic use only	monkey, Cynomolgus	kidney	JCRB0607	MK.P3(F)	other name is JTC-12.P3(F)
monkey, rhesus:hemo-lymphocytic Top
Japan Domestic use only	monkey, rhesus	hemo-lymphocytic	JCRB1644	HSR-1	Peripheral blood lymphocyte cell line of rhesus monkey (immortalized by Herpesvirus saimiri).
Japan Domestic use only	monkey, rhesus	hemo-lymphocytic	JCRB1641	HSR-4	Peripheral blood lymphocyte cell line of rhesus monkey (immortalized by Herpesvirus saimiri).
mosquito:hatched larvae Top
	mosquito	hatched larvae	IFO50010	C6/36	This cell line is useful for replication of flavoviruses and dengue virus.
mouse: Top
	mouse		JCRB1621	hTf2-9F/sf	This cell line produce monoclonal antibody against human transferrin.
	mouse		JCRB1632	VV-1H831	Mouse hybridoma producing mAb (IgG1) to hemagglutinine (HA) of vaccinia virus.
mouse:adrenal cortex Top
	mouse	adrenal cortex	JCRB9056	Y-1	adrenocortical tumor, steroid-secreting, (LAF1 mouse)
mouse:antibody-producing hybridoma Top
	mouse	antibody-producing hybridoma	JCRB0013	16-8	Mouse hybridoma cell line producing monoclonal antibody to human erythrocyte.
	mouse	antibody-producing hybridoma	JCRB0014	19-7	Mouse hybridoma cell line producing monoclonal antibody to human erythrocyte.
	mouse	antibody-producing hybridoma	JCRB0084	4-2D	anti-primase complexed with DNA polymerase alpha
	mouse	antibody-producing hybridoma	JCRB0083	4-8H	anti-DNA polymerase alpha, IgG1
	mouse	antibody-producing hybridoma	IFO50284	A2B5 clone 105	Produces anti-chick retinal neuron glycolipid monoclonal antibody (IgM class).
	mouse	antibody-producing hybridoma	JCRB1392	AS17	Hybridoma cell line producing antibody against human annexin IV.
	mouse	antibody-producing hybridoma	JCRB1213.3	DIG104.10H.1	Mouse hybridoma cell line producing monoclonal antibody against digoxin.
	mouse	antibody-producing hybridoma	JCRB1213.2	DIG222.4D.5	Mouse hybridoma cell line producing monoclonal antibody against digoxin.
	mouse	antibody-producing hybridoma	JCRB1324	F119	Mouse hybridoma cell line producing F119 MAb against CD307(IRTA2/FcRH5/FCRL5).
	mouse	antibody-producing hybridoma	JCRB1323	F25	Mouse hybridoma cell line producing F25 MAb against CD307 (IRTA2/FcRH5/FCRL5).
	mouse	antibody-producing hybridoma	JCRB1189	F56	Mouse hybridoma cell line producing F56 MAb against CD307(IRTA2/FcRH5/FCRL5).
	mouse	antibody-producing hybridoma	JCRB1226	GHBP116	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone receptor (GHBP116).
	mouse	antibody-producing hybridoma	JCRB1381	HBs128	Mouse hybridoma cell line producing monoclonal antibody against HBs antigen.
	mouse	antibody-producing hybridoma	JCRB1380	HBs320	Mouse hybridoma cell line producing monoclonal antibody against HBs antigen.
	mouse	antibody-producing hybridoma	JCRB1222.01	HGH1.1.3	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.08	HGH1.11.1	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.09	HGH1.15.3	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.03	HGH1.17.2	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.12	HGH1.31.3	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.13	HGH1.32.4	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.04	HGH1.35.2	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.14	HGH1.37.3	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.10	HGH1.41.1	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.11	HGH1.46.1	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.02	HGH1.6.5	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.07	HGH1.8.1	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.06	HGH1.9.3	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.15	HGH2.4.2	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1222.05	HGH2.6.1	Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
	mouse	antibody-producing hybridoma	JCRB1314	HPSV178-4-3	Hybridoma cell line producing mAb HPSV178, against the C-terminal portion of PrPSV (residues 214-230).
	mouse	antibody-producing hybridoma	JCRB1603	hTf18-10C	This cell line produce monoclonal antibody against human transferrin.
	mouse	antibody-producing hybridoma	JCRB1611	hTf18-10C/sf	This cell line produce monoclonal antibody against human transferrin.
	mouse	antibody-producing hybridoma	JCRB1504	hTf2-9F	This cell line produces monoclonal antibody against human transferrin.
	mouse	antibody-producing hybridoma	JCRB1613	hTf26-9B	This cell line produce monoclonal antibody against human transferrin.
	mouse	antibody-producing hybridoma	JCRB1599	hTf30-8H	This cell line produce monoclonal antibody against human transferrin.
	mouse	antibody-producing hybridoma	JCRB1602	hTf30-8H/sf	This cell line produce monoclonal antibody against human transferrin.
	mouse	antibody-producing hybridoma	JCRB1617	hTf9-11E	This cell line produce monoclonal antibody against human transferrin.
	mouse	antibody-producing hybridoma	JCRB0090	MB86	anti-Igh6-4 antibody-producing, IgM, (BALB/c mouse)
	mouse	antibody-producing hybridoma	JCRB1342.06	MOR115.1.13	Mouse hybridoma cell line producing monoclonal antibody against morphine.
	mouse	antibody-producing hybridoma	JCRB1342.07	MOR124.2.2	Mouse hybridoma cell line producing monoclonal antibody against morphine.
	mouse	antibody-producing hybridoma	JCRB1342.08	MOR131.5.13	Mouse hybridoma cell line producing monoclonal antibody against morphine.
	mouse	antibody-producing hybridoma	JCRB1342.09	MOR158.1.3	Mouse hybridoma cell line producing monoclonal antibody against morphine.
	mouse	antibody-producing hybridoma	JCRB1342.11	MOR180.2.4	Mouse hybridoma cell line producing monoclonal antibody against morphine.
	mouse	antibody-producing hybridoma	JCRB1342.10	MOR33.2.9	Mouse hybridoma cell line producing monoclonal antibody against morphine.
	mouse	antibody-producing hybridoma	JCRB1342.02	MOR35.4.12	Mouse hybridoma cell line producing monoclonal antibody against morphine.
	mouse	antibody-producing hybridoma	JCRB1342.03	MOR39.3.9	Mouse hybridoma cell line producing monoclonal antibody against morphine.
	mouse	antibody-producing hybridoma	JCRB1342.12	MOR44.4.1	Mouse hybridoma cell line producing monoclonal antibody against morphine.
	mouse	antibody-producing hybridoma	JCRB1342.04	MOR76.7F.16	Mouse hybridoma cell line producing monoclonal antibody against morphine.
	mouse	antibody-producing hybridoma	JCRB1342.01	MOR8.2.1	Mouse hybridoma cell line producing monoclonal antibody against morphine.
	mouse	antibody-producing hybridoma	JCRB1342.05	MOR83.3.10	Mouse hybridoma cell line producing monoclonal antibody against morphine.
	mouse	antibody-producing hybridoma	JCRB1304	MT-45-5-3	Mouse hybridoma cell line producing monoclonal antibody against metallothionein.
	mouse	antibody-producing hybridoma	IFO50279	NKY113	SP21/0-Ag14 myeloma x spleen from mouse immunized with a human colon adenocarcinoma SW1116. This cell line produces MSW113 monoclonal antibody. MSW113 monoclonal antibody recognizes a cancer associated antigenm sialyl-Le^a oligosaccharide.
	mouse	antibody-producing hybridoma	JCRB1316.2	OHP101.B11.1	Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone.
	mouse	antibody-producing hybridoma	JCRB1316.3	OHP138.H8.1	Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone.
	mouse	antibody-producing hybridoma	JCRB1316.4	OHP1E9.3.1	Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone.
	mouse	antibody-producing hybridoma	JCRB1316.1	OHP57.G6.1	Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone.
	mouse	antibody-producing hybridoma	JCRB1316.6	OHP7D7.2.3	Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone.
	mouse	antibody-producing hybridoma	IFO50466	RC1	This cell line produces a monoclonal antibody RC1 (IgG class). Immunochistochemically, RC1 antibody reacts with radial glia and neural progenitor cells in CNS.
	mouse	antibody-producing hybridoma	JCRB0195	RP-1	Mouse cell line producing IgG1 against rat neutrophil.
	mouse	antibody-producing hybridoma	JCRB0196	RP-3	Mouse cell line producing IgM antibody against rat neutrophil. The antibody is harmfull to the rat neutrophil in vivo or in vitro with complement.
	mouse	antibody-producing hybridoma	JCRB0011	S.CET.M8.1.1	Mouse hybridoma cell line releasing monoclonal anti-11-deoxycortisol antibody.
	mouse	antibody-producing hybridoma	JCRB1301	SC78.H81.C81.A9	Mouse hybridoma cell line producing monoclonal antibody against scopolamine.
	mouse	antibody-producing hybridoma	JCRB9032	SJK-237-71	anti-DNA polymerase alpha, IgG1
	mouse	antibody-producing hybridoma	JCRB1358.04	SRBC-F12-1-19	Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
	mouse	antibody-producing hybridoma	JCRB1358.05	SRBC-F12-18-7	Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
	mouse	antibody-producing hybridoma	JCRB1358.06	SRBC-F23-20-22	Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
	mouse	antibody-producing hybridoma	JCRB1358.08	SRBC-F31-19-1	Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
	mouse	antibody-producing hybridoma	JCRB1358.07	SRBC-F31-2-11	Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
	mouse	antibody-producing hybridoma	JCRB1358.01	SRBC-P13-7-3	Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
	mouse	antibody-producing hybridoma	JCRB1358.02	SRBC-P18-3-8	Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
	mouse	antibody-producing hybridoma	JCRB1358.03	SRBC-P20-13-13	Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
	mouse	antibody-producing hybridoma	JCRB1358.11	SRBC-RF29-1-3	Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
	mouse	antibody-producing hybridoma	JCRB1358.10	SRBC-RP8-18-15	Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
	mouse	antibody-producing hybridoma	JCRB1358.09	SRBC-RP8-2-4	Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
	mouse	antibody-producing hybridoma	JCRB9033	STK1	anti-DNA polymerase alpha, IgG1
	mouse	antibody-producing hybridoma	JCRB1311	ZEN	Mouse hybridoma cell line producing monoclonal antibody against zearalenone.
mouse:ascites Top
	mouse	ascites	JCRB9090	Ehrlich ascites	Ehrlich-Lettre ascites carcinoma
	mouse	ascites	JCRB0424	JTC-11	In vitro adapted strain of Ehrlich ascites carcinoma.
mouse:bladder Top
	mouse	bladder	IFO50041	MBT2	bladder carcinoma
mouse:bone marrow Top
	mouse	bone marrow	JCRB1181	9-15c	Mouse C3H/He cell line.
	mouse	bone marrow	JCRB1548	H-1A(H123)	Mouse bone marrow-derived osteoblast-like cell line.
	mouse	bone marrow	JCRB1570	H-1D(H162)	Mouse bone marrow-derived osteoblast-like cell line.
	mouse	bone marrow	JCRB1176	KUM10	Osteoblast cell line from mouse C57/B6 bone marrow.
	mouse	bone marrow	JCRB1134	KUM3	Osteoblast cell line from Mouse C3H bone marrow.
	mouse	bone marrow	JCRB1135	KUM4	Osteoblastic cell line of mouse C3H.
	mouse	bone marrow	JCRB1178	KUM5	Osteoblastic cell line of mouse C3H.
	mouse	bone marrow	JCRB1202	KUM6	Osteoblastic cell line
	mouse	bone marrow	JCRB1204	KUM7	Osteoblastic cell line
	mouse	bone marrow	JCRB1139	KUM9	Osteoblastic cell line of mouse C3H.
	mouse	bone marrow	JCRB1132	KUSA-0	Mouse osteoblastic cell line.
	mouse	bone marrow	JCRB1119	KUSA-A1	Mouse osteoblastic cell line.
	mouse	bone marrow	JCRB1129	KUSA-H1	mouse osteoblastic cell line
	mouse	bone marrow	JCRB1138	NRG	Osteoblastic cell line of mouse C3H.
mouse:embryo Top
	mouse	embryo	JCRB1355	1-1ras1000	The ras-transformed BALB/c 3T3 A31-1-1variant cell lines were strongly tumorinenic, but the cells were not metastatic. (Strain problem was found. Refer Important Notice at cell detail page.)
	mouse	embryo	JCRB1357	1-1src	The src-transformed BALB/c 3T3 A31-1-1 variant cell lines were strongly tumorinenic and metastatic.(Strain problem was found. Refer Important Notice at cell detail page.)
	mouse	embryo	JCRB9014	3T3 L1	Clonal subline of the mouse 3T3 that accumulate large amounts of triglyceride fat when the cells are in the resting state.
	mouse	embryo	IFO50416	3T3-L1	3T3 L1 cell line is a substrain of 3T3-Swiss albino cell line. 3T3 L1 cells convert adipose-like cells at confluent.
	mouse	embryo	JCRB9019	3T3-Swiss albino	fibroblast, contact inhibited, (Swiss albino mouse)
	mouse	embryo	IFO50417	3T3-Swiss albino	fibroblast, contact inhibited, (Swiss albino mouse)
	mouse	embryo	JCRB9059	3T6-Swiss albino	fibroblast, collagen-secreting, (Swiss albino mouse)
	mouse	embryo	JCRB1356	A31-1-1	fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.)
	mouse	embryo	IFO50021	A31-714 C4	fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
	mouse	embryo	JCRB0601	BALB/3T3 A31-1-1	fibroblast, contact inhibited, (Strain problem was found. Refer Important Notice at cell detail page.)
	mouse	embryo	JCRB9005	BALB/3T3 clone A31	fibroblast, contact inhibited, (BALB/c mouse)
	mouse	embryo	IFO50070	Balb/3T3-A31-1-1	fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.)
	mouse	embryo	IFO50299	Balb/c 3T3 A31-1-13	fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.)
	mouse	embryo	IFO50298	Balb/c 3T3 A31-I-1	fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.)
	mouse	embryo	JCRB0149	Bhas 42	BALB 3T3 A31-1-1 cell line transfected with H-ras gene. The cell line keeps characteristics of the contact inhibition and the transfomation is induced by phorbol ester alone. No initialization required. (Strain problem was found. Refer Important Notice at cell detail page.)
	mouse	embryo	JCRB9080	C3H/10T1/2 clone 8	fibroblast, contact inhibited, (C3H mouse)
	mouse	embryo	JCRB0003	C3H/10T1/2-clone 8	fibroblast, contact inhibited, (C3H mouse)
	mouse	embryo	IFO50415	C3H/10T1/2-clone8	This cell line is useful for transformation studies.
	mouse	embryo	IFO50042	C3H/MCA clone 15	Parent strain is C3H/10T/1/2 clone 8.
	mouse	embryo	JCRB0712	MCA-TCL16	C3H10T1/2 cl-8 derivative, methylcholanthrene-transformed, (C3H mouse) This cell line is found to be contaminated by mycoplasmas.
	mouse	embryo	JCRB1914	MEF-N7	Mouse Embryonic Fibroblast, derived from 12.5 day fetus, ICR, naturally immortalized cell line, can be used as a feeder
	mouse	embryo	IFO50019	NIH 3T3 p-7 cl-3	fibroblast (NIH Swiss mouse)
	mouse	embryo	JCRB0615	NIH/3T3 clone 5611	A cell line which was established from NIH Swiss mouse embryo.
	mouse	embryo	JCRB9099	SV-T2	SV40 virus-transformed BALB/3T3, (BALB/c mouse)
mouse:fibroblast Top
	mouse	fibroblast	JCRB0732	A9(0439)-1	contains human chromosome Xpter>Xq26::3p12>3pter (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB0730	A9(2621)-4	contains human chromosome 12pter>12q24::Xq22>Xqter (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB0731	A9(3552)-2	contains human chromosome 11pter>11q23::Xq26>Xqter (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB0729	A9(3884)-1	contains human chromosome 16pter>16q24::Xq26>Xqter (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB0728	A9(7151)-3	contains human chromosome 17pter>17q11::Xq11>Xqter (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB0727	A9(An4)-2	contains human chromosome # 1 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2210	A9(Bsr10)	contains human chromosome #10 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2223	A9(BsrX)	contains human chromosome X (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2213	A9(Hygro13)	contains human chromosome #13 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2214	A9(Hygro14)	contains human chromosome #14 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2221	A9(Hygro21)	contains human chromosome #21 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2222	A9(Hygro22)	contains human chromosome #22 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2201	A9(Neo1)	contains human chromosome # 1 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2211	A9(neo11)	contains human chromosome #11 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2212	A9(Neo12)	contains human chromosome #12 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2215	A9(Neo15)	contains human chromosome #15 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2216	A9(Neo16)	contains human chromosome #16 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2217	A9(Neo17)	contains human chromosome #17 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2218	A9(Neo18)	contains human chromosome #18 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2219	A9(Neo19)	contains human chromosome #19 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2202	A9(Neo2)	contains human chromosome # 2 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2220	A9(Neo20)	contains human chromosome #20 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2203	A9(Neo3)	contains human chromosome # 3 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2204	A9(Neo4)	contains human chromosome # 4 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2205	A9(Neo5)	contains human chromosome # 5 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2206	A9(Neo6)	contains human chromosome # 6 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2207	A9(Neo7)	contains human chromosome # 7 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB2208	A9(Neo8)	contains human chromosome # 8 (MTA with Tottori Univ. is required.)
	mouse	fibroblast	JCRB0726	A9(NTI8)-2	contains human chromosome # 7 (MTA with Tottori Univ. is required.)
mouse:hemo-lymphocytic Top
	mouse	hemo-lymphocytic	JCRB0238	B8/3	Mouse erythroleukemia cell line.
	mouse	hemo-lymphocytic	JCRB9117	BCL1 Clone CW13.20	Mouse B cell line, where the differentiation is stimulated by B cell differentiation factors.
	mouse	hemo-lymphocytic	JCRB9002	BW5147.G.1.4.OUA-R.1	lymphoma, T cell lymphoma, (AKR/J mouse)
	mouse	hemo-lymphocytic	JCRB1350	EL-4	EL-4 was established from a lymphoma induced in a C57BL mouse by 9,10-dimethyl-1,2-benzanthracene.
	mouse	hemo-lymphocytic	JCRB1352	EL-4ad	A valiant cell line which adhered to a tissue culture dish was isolated from highly metastatic EL-4 murine T-lymphoma.
	mouse	hemo-lymphocytic	IFO50111	GRSL	thymic leukemia, (GR/A mouse)
	mouse	hemo-lymphocytic	JCRB0018	J774.1	monocyte-macrophage, IL-1-producing, (BALB/c mouse)
	mouse	hemo-lymphocytic	JCRB9026	L1210	leukemia, lymphocytic, (DBA/2 mouse)
	mouse	hemo-lymphocytic	JCRB0709	L5178Y	lymphoma, methylcholanthrene induced, (DBA/2 mouse)
	mouse	hemo-lymphocytic	JCRB0709.1	L5178Y TK+/-3.7.2c	Mouse TK+/- heterozygotic subline of the L5178Y.
	mouse	hemo-lymphocytic	JCRB0723	L5178Y ts2	L5178Y derivative, abnormal cell division at non-permissive temperature
	mouse	hemo-lymphocytic	JCRB0724	L5178Y ts39	A ts strain derived from L5178Y. Micronucleation observed at the non-permissive temperature (39 C).
	mouse	hemo-lymphocytic	IFO50006	M1	Spontaneously occurred mouse myeloid leukemia, differentiate into macrophage/granulocyte.
	mouse	hemo-lymphocytic	JCRB0110	M1-T22	Spontaneously occured myeloid leukemia cell line differentiated by dexamethasone or etc.
	mouse	hemo-lymphocytic	IFO50008	Mm1	spontaneous myeloid leukemia, M-1-derivative, macrophage-like phenotype, (SL mouse)
	mouse	hemo-lymphocytic	JCRB9106	MPC 11 OUAr	myeloma, ourbain resistant
	mouse	hemo-lymphocytic	JCRB0078	P-815	mastocytoma, (DBA/2 mouse)
	mouse	hemo-lymphocytic	JCRB9109	P3.6.2.8.1	myeloma, IgG1 secreting, (BALB/c mouse)
	mouse	hemo-lymphocytic	JCRB0009	P3/NS1/1-Ag4-1	Mouse plasmacytoma cell line resistant to 8-azaguanine.
	mouse	hemo-lymphocytic	JCRB9107	P3/NS1/1-Ag4-1(NS-1)	myeloma, plasmacytoma, non-secreting, 8-azaguanine resistant
	mouse	hemo-lymphocytic	JCRB0017	P388	MCA induced lymphoid mouse neoplasma cell line.
	mouse	hemo-lymphocytic	JCRB0016	P388-D1	lymphoid neoplasm, derived from P388, (DBA/2 mouse)
	mouse	hemo-lymphocytic	IFO50036	P388D1	lymphoid neoplasm, derived from P388, (DBA/2 mouse)
	mouse	hemo-lymphocytic	JCRB0708	P3U1	myeloma
	mouse	hemo-lymphocytic	JCRB9030	P3X63-Ag8.653	myeloma, non-secreting, 8-azaguanine resistant, (BALB/c mouse)
	mouse	hemo-lymphocytic	JCRB9105	P3X63Ag8	myeloma, plasmacytoma, IgG1(gamma,kappa) secreting, (BALB/c mouse)
	mouse	hemo-lymphocytic	JCRB9085	P3X63Ag8U.1	myeloma, plasmacytoma, 8-azaguanine resistant, (BALB/c mouse)
	mouse	hemo-lymphocytic	JCRB0113	PAI	myeloma, (BALB/c mouse)
	mouse	hemo-lymphocytic	IFO50267	PB-3c	IL-3-dependent mouse bone marrow cell line.
	mouse	hemo-lymphocytic	JCRB9084	Sp2/O-Ag14	myeloma, non-secreting, 8-azaguanine resistant
	mouse	hemo-lymphocytic	JCRB9093	WEHI-3	leukemia, myelomonocytic, macrophage-like, (BALB/c mouse)
	mouse	hemo-lymphocytic	IFO50296	WEHI-3b	myelomonocyte, (BALB/c mouse)
mouse:hybridoma Top
	mouse	hybridoma	JCRB1213.1	DIG64.2B.5	Mouse hybridoma cell line producing monoclonal antibody against digoxin.
	mouse	hybridoma	JCRB1316.5	OHP4B2.2.3	Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone.
mouse:kidney Top
	mouse	kidney	IFO50373	TKC2	cAMP synthesis is stimulated by arginine vasopressin in the cells. Growth temperature is 33 C.
mouse:liver Top
	mouse	liver	IFO50377	FLS3	This cell line supports B-cell differentiation. (Blood, 77,2612,(1991)).
	mouse	liver	IFO50378	FLS5	Mouse liver stromal cell line.
	mouse	liver	JCRB9075	NCTC Clone 1469	Normal cell line from mouse liver.
	mouse	liver	IFO50080	NCTC clone 1469	The NCTC clone 1469 is a subline of NCTC 721.
	mouse	liver	IFO50379	TLR2	P450IA1 mRNA is induced by methylcholanthrene. Growth temperature is 33 C.
	mouse	liver	IFO50380	TLR3	P450IA1 mRNA is induced by methylcholanthrene. Growth temperature is 33 C.
mouse:lung Top
	mouse	lung	JCRB1349	Ex-3LL	Variant cell line possessing enhanced lung metastasis ability derived from Lewis lung cancer (3LL).
	mouse	lung	JCRB1351	Int-3LL	Variant cell line possessing enhanced intravasating ability derived from Lewis lung cancer (3LL).
mouse:lung cancer Top
	mouse	lung cancer	JCRB1348	3LL	Lewis lung carcinoma cell line.
mouse:macrophage Top
	mouse	macrophage	JCRB9108	J774A.1	Mouse macrophage cell line.
mouse:mammary Top
	mouse	mammary	JCRB0233.0	BALB-MC	mammary cancer, (BALB/cHe mouse)
	mouse	mammary	JCRB0233.1	BALB-MC.D3	mammary cancer, (BALB/cHe mouse)
	mouse	mammary	JCRB0233.2	BALB-MC.E12	Mouse mammary tumor cell line.
	mouse	mammary	JCRB1077	DD-762	Mouse mammary tumor cell line producing MuMTV.
	mouse	mammary	JCRB0701	FM3A	mammary carcinoma, spontaneously obtained, (C3H/He mouse)
	mouse	mammary	JCRB0703	FM3A APRT~	mammary carcinoma, APRT-deficient FM3A, (C3H/He mouse)
	mouse	mammary	JCRB0702	FM3A HPRT~	mammary carcinoma, HPRT-deficient FM3A , (C3H/He mouse)
	mouse	mammary	JCRB0704	FM3A TK~	mammary carcinoma, thymidine kinase-deficient FM3A, (C3H/He mouse)
	mouse	mammary	JCRB9077	MMT 060562	spontaneous mammary tumor
	mouse	mammary	JCRB1413	ST 13	Mouse normal preadipocyte cell line established from ddN mouse. ST 13 can be induced to differentiate into fat-accumulating cells in vitro.
	mouse	mammary	JCRB0705	ts85	FM3A derivative, defective in ubiquitin activating enzyme, (C3H mouse)
	mouse	mammary	JCRB0706	tsFT101	FM3A derivative, cytokinesis is blocked at 39 C, (C3H mouse)
mouse:melanoma Top
	mouse	melanoma	JCRB0202	B16 melanoma	Mouse skin melanoma cell line.
mouse:neural Top
	mouse	neural	IFO50519	A1	derives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells
	mouse	neural	IFO50424	AP-16	Astrocyte differentiation is induced by TGF-beta, LIF, CNTF and serum The deprivation of EGF induces death of AP-16 cells by apoptosis.
	mouse	neural	JCRB1571	F6B3	Mouse cell line derived from mouse brain tumor.
	mouse	neural	IFO50161	KT-5	GFAP and S-100-positive, MBP, thy-1 and neurofilament-negative. (Tested at the IFO.).
	mouse	neural	IFO50293	MA-89	Not immortalized cells. Limited life span.
	mouse	neural	JCRB0145	MEB 5	Multipotent CNS stem cell line of mouse. Cells differentiate into neuron, astrocytes and oligodendrocytes.
	mouse	neural	IFO50472	MEB5	Neural stem cell line established from embryonic 14.5 day mouse cerebrum by E7 oncogene of HPV type 16. Withdrawal of EGF induces apoptosis or differentiation to neurons, astrocytes, and oligodendrocytes. LIF induces differentiation into astrocytes.
	mouse	neural	IFO50520	MG5	A microglial cell line from p53-deficient mice. Requires conditioned medium of A1 cell line (or of astrocytes) for cultivation of MG5 cells.
	mouse	neural	IFO50081	Neuro-2a	Derivative of C1300 tumor. C1300 tumor was originally described as a spontaneous tumor of the region of spinal cord. Later studies suggested that it is drived from sympathetic cells in peripheral nervous system.
	mouse	neural	IFO50495	Neuro-2aTG	This cell line is HPRT-deficient clone from EMS-mutagnenized Neuro-2a cells. HAT-sensitive, 6-thioguanine-registant.
	mouse	neural	JCRB1574	RSV-M	Mouse cell line derived from mouse brain tumor.
	mouse	neural	JCRB1580	SR-CDF1 DBT	Mouse cell line derived from mouse brain tumor.
	mouse	neural	JCRB1361	Vn1919	neuroglial and neuronal character coexpressing ependymoma cell line.
	mouse	neural	JCRB1365	Vn1919 cl4	neuroglial and neuronal character coexpressing ependymoma cell line.
	mouse	neural	JCRB1367	Vn1919 cl49	neuroglial and neuronal character coexpressing ependymoma cell line.
	mouse	neural	JCRB1368	Vn1919 cl59	neuroglial and neuronal character coexpressing ependymoma cell line.
mouse:olfactory epithelium Top
	mouse	olfactory epithelium	IFO50484	DBC1.2	This cell line is likely to be derived from olfactory dark (horizontal) basal cell. Keratin is expressed in this cell line.
mouse:ovary Top
	mouse	ovary	JCRB1026	OV3121	A non-metastatic epitherial tumor cell line established from ovarian granulosa cell tumor irradiated with 60-Co-gamma rays. Cells are producing estradiol continuously.
	mouse	ovary	JCRB0186	OV3121ras4	Mouse ovarian granulosa cell tumor line with v-Ha-ras gene.
	mouse	ovary	JCRB0187	OV3121ras7	Mouse ovarian granulosa cell tumor line with v-Ha-ras gene.
	mouse	ovary	JCRB0151.1	p53-def-MOSE	ovarian surface epithelial cell line from p53(-/-) mouse
	mouse	ovary	JCRB0151	T-Ag-MOSE	Cells are derived from normal ovary of adult C3H/He mouse and immortalized by the plasmid pEF321-T containing T antigen gene. Cells are tumorigenic in nude mice.
mouse:pituitary Top
	mouse	pituitary	JCRB9098	AtT-20	pituitary tumor, ACTH producing, (LAF1 mouse)
mouse:sarcoma Top
	mouse	sarcoma	JCRB9089	CCRF S-180 II	S-180 sarcoma derivative
	mouse	sarcoma	IFO50268	EHS	This cell line secretes basement membrane matrix including laminin and type IV collagen.
mouse:skin Top
	mouse	skin	JCRB0211	A9	skin fibroblast, 8-azaguanine-resistant, (C3H mouse)
	mouse	skin	JCRB0212	B82	skin fibroblast, bromodeoxyuridine-resistant
	mouse	skin	JCRB1198.01	GP8	The mouse SV cell line rescued with a human normal behta-galactosidase gene.
	mouse	skin	JCRB1225	I51T	Mouse behta-galactosidase deficient cell line introduced human defcient bethta-galactosidase gene.
	mouse	skin	JCRB0125	L alpha	L cell line introduced with poliovirus receptor protein alpha gene, thymidine kinase defective
	mouse	skin	JCRB0722	L cl 1D	fibroblast, thymidine kinase-deficient, (C3H mouse)
	mouse	skin	JCRB0648	L.P3	Serum free cell line of the mouse L929 cell line.
	mouse	skin	JCRB0605	L.P3(S)	L cell derived, can grow in a serum-free medium, (C3H mouse)
	mouse	skin	JCRB1322	m5S	Near-diproid mouse embryonic cell line.
	mouse	skin	JCRB9003	NCTC Clone 929	fibroblast, subclone of strain L, (C3H/An mouse)
	mouse	skin	IFO50409	NCTC clone 929	A clone of L cells, and often referred as L929. The L cells was established from normal subcutaneous areolar and adipose tissue.
	mouse	skin	JCRB1207	SV	SV40 immortalized beta-galactosidase gene deficient mouse fibroblast cell line. Human disease animal model mouse (GM1 gangliosidosis) derived cell line.
mouse:spleen Top
	mouse	spleen	IFO50375	MSS31	spleen stromal cell line, (C57BL/6 mouse)
	mouse	spleen	IFO50376	MSS62	spleen stromal cell line, (C57BL/6 mouse)
mouse:teratoma Top
	mouse	teratoma	JCRB0721	F9	teratocarcinoma, differentiation-inducible, (129/Sv mouse)
	mouse	teratoma	JCRB0001	F9-41	Mouse testicular teratocarcinoma cell line.
	mouse	teratoma	JCRB0720	OTT6050	teratocarcinoma, (129/Sv mouse)
	mouse	teratoma	JCRB0206	PCC4 AG	teratocarcinoma, 8-azaguanine-resistant, (129/Sv mouse)
	mouse	teratoma	JCRB0216	PCC4 AG Cap	teratocarcinoma, 8-azaguanine, chloramphenicol-resistant (129/sv mouse)
mouse:testis Top
	mouse	testis	JCRB0243	B-1	Leydig cell tumor, estrogen-dependent, (BALB/c mouse)
	mouse	testis	JCRB9097	I-10	Leydig cell testicular tumor (BALB/cJ mouse)
mouse:thymidylate defective Top
	mouse	thymidylate defective	JCRB0719	FSthy21	complete defective strain of thymidylate synthase, (C3H mouse)
mouse:thymus Top
	mouse	thymus	IFO50248	IT-79MTNC3	thymic nurse cell, (BALB/c mouse)
mouse:vascular system Top
	mouse	vascular system	JCRB0150	P53LMACO1	Smooth muscle cell line established from thoracic aorta of a p53 knock out mouse.
	mouse	vascular system	IFO50374	TKD2	Acetylated low-densitiy lipoprotein is incorporated into the cells. Temperature sensitive cell line. Growth temperature is 33 C.
mouse x human:antibody-producing hybridoma Top
	mouse x human	antibody-producing hybridoma	IFO50090	4G12 hybridoma	This cell line produces human monoclonal 4G12 antibody (Ig lambda). The 4G12 antibody recognizes a glycoprotein with Mr = 65,000. Immunohistochemically, 4G12 reacts especially with lung carcinomas and with some malignant tumors.
mouse x rat:antibody-producing hybridoma Top
	mouse x rat	antibody-producing hybridoma	JCRB9092	7D4	anti-murine IL-2 receptors (rat antibody)
	mouse x rat	antibody-producing hybridoma	JCRB1385	CAS-9	Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/Fibronectin.
	mouse x rat	antibody-producing hybridoma	JCRB1370	TAS-5	Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/VCAM-1 and VLA-4/Fibronectin
	mouse x rat	antibody-producing hybridoma	JCRB1353	TER-119	Hybridoma cell line producing antibody against mouse erythrocyte membrane antigen Ly76.
mouse x rat:cybrid Top
	mouse x rat	cybrid	JCRB0203	PCC4 TypeIII	PCC4 fused with cytoplasts of rat myoblastic cell (L6TG Cap-r)
mouse x rat:neural Top
	mouse x rat	neural	IFO50221	N18-RE-105	Neuron like cells established from mouse N18TG2 x Fischer rat 18 day-embryonic neural retina.
pig:kidney Top
Japan Domestic use only	pig	kidney	JCRB0060	LLC-PK1	susceptible to rubella, vaccinia and herpes viruses
Japan Domestic use only	pig	kidney	JCRB9040	PK(15)	kidney
Japan Domestic use only	pig	kidney	IFO50422	PKF	The name PKF derives from Pig Kidney Fibroblastic.
Japan Domestic use only	pig	kidney	IFO50423	PKR	The name PKR derives from Pig Kidney Rough (outline of cell morphology).
Japan Domestic use only	pig	kidney	IFO50421	PKS	The name PKS derives from Pig Kidney Smooth (outline of cell morphology).
pygmy mouse:tail Top
	pygmy mouse	tail	JCRB9124	M.dunni(Clone III8C)	normal, support the growth of all 4 classes of MuLV
rabbit:cornea Top
	rabbit	cornea	JCRB0246	RC-1	cornea, (white rabbit)
	rabbit	cornea	JCRB9122	SIRC	susceptible to rubella virus
	rabbit	cornea	IFO50020	SIRC	susceptible to rubella virus
rabbit:kidney Top
	rabbit	kidney	JCRB9034	LLC-RK1	an aneuploid cell line, (New Zealand white rabbit)
rabbit:lung Top
	rabbit	lung	JCRB0131	RL-33	Japansese white rabbit lung cell line sensitive to HSV or VSV.
rat:colon Top
	rat	colon	JCRB0167	RCN-9	DMH induced colonic cancer, (F344/DuCrj rat)
rat:embryo Top
	rat	embryo	JCRB0734	3Y1-B Clone 1-6	fibroblast, whole embryo, (Fischer 344 rat)
	rat	embryo	IFO50277	5RP7	fibroblast transformed by c-Ha-ras oncogene
	rat	embryo	JCRB0737	Ad12-3Y1-Z19	3Y1 derivative, Ad12-transformed, (Fischer rat)
	rat	embryo	JCRB0738	E1A-3Y1-1	3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat)
	rat	embryo	IFO50015	F2408	Rat fibroblast cell line.
	rat	embryo	JCRB0143.5	F2408 EBNA2 cl-14	EBNA2-transfected, (Fischer rat)
	rat	embryo	JCRB0143.2	F2408 EBNA2 cl-16	F2408 cell line transfected with recombinant plasmid pZE2 with coding region of the EBNA2 and the expression of the EBNA2 was strong in this strain.
	rat	embryo	JCRB0143.3	F2408 EBNA2 cl-18	Rat embryo cell line transfected by recombinant plasmid pZE2 with coding region of the EBNA2.
	rat	embryo	JCRB0143.6	F2408 EBNA2 cl-23	This cell line is one of a series of F2408 rat cell lines with recombinant plasmid pZE2 with coding region of the EBNA2 transfected, but the expression of the EBNA2 was weak in this strain.
	rat	embryo	JCRB0143.4	F2408 EBNA2 cl-24	EBNA2-transfected, (Fischer rat)
	rat	embryo	JCRB0143.7	F2408 EBNA2 cl-28	F2408 cell line transfected with recombinant plasmid pZE2 having coding region of the EBNA2 but the expression of the EBNA2 was weak.
	rat	embryo	JCRB0143.1	F2408 EBNA2 cl-9	EBNA2-transfected, (Fischer rat)
	rat	embryo	JCRB0143.0	F2408 pZipNeo	F2408 cell line transfected with pZipNeo plasmid alone as a control against pZE2 transfected F2408 cell line series.
	rat	embryo	IFO50099	F2408-B812	HGPRT-deficient line from F2408 (IFO 50015). This cell line exhibits temperature sensitive phenotype for transformation by Moloney MSV.
	rat	embryo	IFO50100	F2408-B993	HGPRT-deficient line from F2408 (IFO 50015). This cell line exhibits temperature sensitive phenotype for transformation by Moloney MSV.
	rat	embryo	IFO50101	F2408-No.20	Thymidine kinase-deficient line from F2408 (IFO 50015).
	rat	embryo	IFO50098	F2408-No.3	HGPRT-deficient line from F2408 (IFO 50015).
	rat	embryo	IFO50102	F2408-No.7	HGPRT-deficient line from F2408 (IFO 50015).
	rat	embryo	JCRB0743	HR-3Y1-2	3Y1 derivative, transformed by v-H-ras cDNA, (Fischer rat)
	rat	embryo	JCRB0739	NG-3Y1-T15L	3Y1 derivative, transformed by MNNG, (Fischer rat)
	rat	embryo	JCRB0740	NG-3Y1-T308	3Y1 derivative, transformed by MNNG, (Fischer rat)
	rat	embryo	JCRB0741	NG-3Y1-T6R	3Y1 derivative, transformed by MNNG, (Fischer rat)
	rat	embryo	JCRB0736	Py-3Y1-S2	3Y1 derivative, mouse polyoma virus-transformed, (Fischer rat)
	rat	embryo	IFO50282	RAT-2	thymidine kinase deficient RAT-1 (F2408) cell line, (Fischer rat)
	rat	embryo	JCRB0742	SR-3Y1-2	3Y1 derivative, transformed by Rous sarcoma virus, (Fischer rat)
	rat	embryo	JCRB0735	SV-3Y1-C66	3Y1 derivative, SV40-transformed, (Fischer rat)
	rat	embryo	JCRB0153.2	tsJT16	Rat 3Y1 derived ts mutant cell line for cell cycle progression from G0 and G1 to S phase.
	rat	embryo	JCRB0153.3	tsJT60	Rat 3Y1 derived ts mutant cell line with cell cycle arrest at G0 phase.
	rat	embryo	JCRB0153.1	tsJT663	Rat embryo cell line with ts mutation for cell cycle progression from G1 to S phase.
rat:hemo-lymphocytic Top
	rat	hemo-lymphocytic	JCRB0168	c-WRT-7-LR	A transplantable rat myelomonocytic leukemia cell line induced in a WKA rat by neonatal injections of RLV (Rauscher leukemia virus).
	rat	hemo-lymphocytic	IFO50034	RBL-1	leukemia, basophilic (Wistar rat)
	rat	hemo-lymphocytic	JCRB0241	Shay	granurocytic sarcoma, (Wister rat)
	rat	hemo-lymphocytic	JCRB9091	Y3-Ag 1.2.3	myeloma, kappa secreting, 8-azaguanine resistant, (Lou rat)
rat:kidney Top
	rat	kidney	IFO50280	77N1	Parental strain is NRK (normal rat kidney) cells (J. Bacteriol.,92, 1133 (1966)).
	rat	kidney	JCRB1585	ACI-RCC	Rat chemically induced renal cell carcinoma cell line. (induced by ferric nitrilotriacetate (Fe-NTA))
	rat	kidney	JCRB9067	NRK-49F	fibroblastic clone of NRK (normal rat kidney) cells, useful for transformation assays, (Osbone-Mendel rat)
	rat	kidney	IFO50481	NRK-49F	NRK-49F is a fibroblastic clone of NRK (mixed culture of normal rat kidney) cells. (J. Bacteriol., 92, 1133 (1966)). This cell line exhibits contact inhibition and is useful for transformation assays.
	rat	kidney	IFO50480	NRK-52E	NRK-52E is a epithelioid clone of NRK (mixed culture of normal rat kidney) cells. (J. Bacteriol., 92, 1133 (1966)).
rat:leukemia Top
	rat	leukemia	JCRB0023	RBL-2H3	Famous rat mast cell line releasing IgE mediated histamine, established from peripheral blood with basophilic leukemia.
rat:liver Top
	rat	liver	JCRB0431	3'-mRLh-2	hepatoma, (Donryu rat)
	rat	liver	JCRB0421	3'-mRLN-30	liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
	rat	liver	JCRB0422	3'-mRLN-31	liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
	rat	liver	JCRB0408	Ac2F	normal liver, diploid, (Donryu rat)
	rat	liver	JCRB0416	Ac2F(DT)	Ac2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat)
	rat	liver	JCRB0417	Ac2F(ST)	Ac2F-derived, spontaneously transformed, (Donryu rat)
	rat	liver	JCRB0714.1	AH-7974.P3	Serum free rat ascited hepatoma cell line. Cells have been maintained by passage for long time. Extremely high passage number.
	rat	liver	JCRB0132.1	AH601(JTC27)	A transplantable rat hepatoma cell line derived from ascites.
	rat	liver	JCRB0132.2	AH601.P3(JTC27)	AH-601 cell line adapted to a serum free medium.
	rat	liver	JCRB0132.3	AH601.P3(JTC27)	AH-601 cell line adupted to a serum free medium with long passage history.
	rat	liver	JCRB0411	AH66tc	ascites hepatoma, (Donryu rat)
	rat	liver	JCRB0412	AH70Btc	ascites hepatoma, (Donryu rat)
	rat	liver	JCRB0248	ARLJ301-3	liver epithelial cell, (F344/DuCrj rat)
	rat	liver	JCRB0025	BRL-3A	MSA (somatomedin-like) protein producing, (Buffalo rat)
	rat	liver	JCRB9114	BRL-3A	MSA (somatomedin-like) protein producing, (Buffalo rat)
	rat	liver	JCRB0409	dRLa-74 Clone 2	liver adenoma, (Donryu rat)
	rat	liver	JCRB0410	dRLh-84	hepatoma, (Donryu rat)
	rat	liver	JCRB0418	dRLN-4	liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
	rat	liver	JCRB0420	dRLN-6	liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
	rat	liver	JCRB0419	dRLN-9	liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
	rat	liver	JCRB0249	FAA-HTC1	hepatocellular carcinoma, 2-acetylaminofluorene induced, (F344/DuCrj rat)
	rat	liver	JCRB1040	FF101	Rat hepatoma cell line with producing unidentified growth factor maintained in serum-free RPMI1640 medium for 444 passages.
	rat	liver	JCRB0610	IAR-20	non-transformed live cell line, (BD-IV rat)
	rat	liver	JCRB0714	JTC-16 P3	Serum free rat ascites hepatoma cell line.
	rat	liver	JCRB0152.1	M	Cell line which is derived from RLC-3 (JAR rat) after 54 day-culture by Nagisa method with treatment of DAB(10ug/ml) for one week. Cells are capable to form collagen network.
	rat	liver	JCRB0152.2	M.P3	M cells derived from RLC-3 (JAR rat) was habituated to serum free culture medium.
	rat	liver	JCRB0152.3	M.P3	M cells derived from RLC-3 (JAR rat) was habituated to serum free culture medium.
	rat	liver	JCRB1088	RI-T	Rat hepatic stellate cell(HSC) line immortalized with SV40 T antigen.
	rat	liver	JCRB0247	RL-34	normal, collagen-induced growth arrest, (Wistar rat)
	rat	liver	JCRB0718	RLC-10.P3	Serum free cell culture derived from rat liver.
	rat	liver	JCRB0718.1	RLC-10.P3	Rat normal cell line cultured with serum free medium for long passages.
	rat	liver	JCRB0415	RLN-10	normal liver, (Donryu rat)
	rat	liver	JCRB0414	RLN-8	normal liver, (Donryu rat)
	rat	liver	JCRB0402	RLN-B2	normal liver, (Donryu rat)
	rat	liver	JCRB0407	RLN-J-5-2	normal liver, (Donryu rat)
	rat	liver	JCRB0193	WB-F344	Normal liver epitherial cell line from rat, Fischer-344.
rat:lung Top
	rat	lung	JCRB0229	EGV-4T	immortal cell line from MNNG-transformed tracheal epithelial cells
	rat	lung	JCRB0608	JTC19	lung, (JAR-1 rat)
	rat	lung	JCRB9053	L-2	adult lung
rat:lymph node Top
	rat	lymph node	JCRB0144.1	LYM-1.P3	The cells are cultured under serum free condition that are derived from lymph node. Cells are sticky to culture dishes.
	rat	lymph node	JCRB0144.1B	LYM-1.P3B	Serum free FAR-2.F60 rat cell culture from lymph node near colon cancer.
	rat	lymph node	JCRB0144.1D	LYM-1.P3D	Serum free FAR-2.F60 rat cell culture from lymph node near colon cancer.
rat:mammary Top
	rat	mammary	JCRB0242	RMT-1 E4	DMBA induced rat mammary carcinoma cell line.
	rat	mammary	JCRB0245	RMT-1 M2	Rat mammary carcinoma cell line from rat mammary gland induced by single shot DMBA(20mg) administrated by oral.
rat:muscular system Top
	rat	muscular system	JCRB9081	L6	skeletal muscle myoblast
	rat	muscular system	IFO50364	L6	skeletal muscle myoblast
	rat	muscular system	JCRB0209	L6TG	skeletal muscle myoblast, 6-thioguanine-resistant
	rat	muscular system	JCRB0210	L6TG Cap	skeletal muscle myoblast, 6-thioguanine, chloramphencol-resistant
rat:neural Top
	rat	neural	JCRB9096	C6	glial tumor, GFAP-positive
	rat	neural	IFO50110	C6	glial tumor, GFAP-positive
	rat	neural	IFO50425	C6-SF2	C6 subline adapted to serum-free medium
	rat	neural	IFO50490	MDM2-RNB	human MDM2 protein-expressing astrocyte cell line, (Wistar rat)
	rat	neural	JCRB0733	PC-12	pheochromocytoma, , neuronal differentiation by NGF, adhesive variant
	rat	neural	IFO50278	PC-12	pheochromocytoma, neuronal differentiation by NGF, grow in suspension
	rat	neural	JCRB0130	PC-12.P3	Rat pheochromo cytoma cell line derived from adrenal medulla. Use serum free DM201 media.
	rat	neural	IFO50496	PC-12TG	HAT-sensitive, 6-thioguanine-resistant.
	rat	neural	JCRB0130.1	PC12.P3	PC-12 derivative adapted to serum-free culture, direct deposition by original developer.
	rat	neural	JCRB0266	PC12HS	Highly NGF sensitive clone of rat PC12 cell line.
	rat	neural	JCRB0263.1	PC12HS.P3	Serum free NGF sensitive PC12HS cell line.
	rat	neural	JCRB0268	PC12IS	NGF insensitive clone of rat PC12 cell line.
	rat	neural	JCRB0267	PC12MS	Moderately NGF sensitive clone of rat PC12 cell line.
	rat	neural	JCRB0129.1	RCR-1	Rat astrocyte-like cells producing GFAP. Serum free cell line (RCR-1.P3) is also available.
	rat	neural	JCRB0129.0	RCR-1.P3	Rat astrocyte-like cell line prducing GFAP in serum free cell culture. Parental strain of this cell line is also available(JCRB0129.1).
	rat	neural	IFO50491	RNB	RNB cells are the parent cells of MDM2-RNB cells (IFO 50490).
rat:pituitary Top
	rat	pituitary	JCRB9046	GH1	pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
	rat	pituitary	IFO50269	GH1	pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
	rat	pituitary	JCRB9047	GH3	pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
	rat	pituitary	IFO50105	GH3	Rat pituitary tumor secreting somatotrophin.
rat:sarcoma Top
	rat	sarcoma	JCRB1001.1	MS-653-A	Highly metastatic rat fibrosarcoma cell line induced by methylcholanthrene.
	rat	sarcoma	JCRB1001.2	MS-653-G	Rat fibrosarcoma cell line induced by methylcholanthrene.
	rat	sarcoma	JCRB0259	MSK	osteosarcoma, 32P-induced, (F344 rat)
	rat	sarcoma	IFO50017	XC	RSV-induced sarcoma, useful for assay of murine leukemia virus, (Wistar rat)
rat:skin Top
	rat	skin	JCRB0005	FRSK	Fetal rat skin keratinocyte cell line.
rat:spleen Top
	rat	spleen	JCRB0423	RS-A	spleen, spontaneously transformed cells, (Donryu rat)
rat:squamous cell carcinoma Top
	rat	squamous cell carcinoma	JCRB0230	SCC-131	Rat squamous cell carcinoma cell line.
	rat	squamous cell carcinoma	JCRB0231	SCC-158	squamous cell carcinoma
rat:submandibular gland Top
	rat	submandibular gland	JCRB1146	RSMG-1	Stem cell like cell line from female rat submandibular gland.
rat:testis Top
	rat	testis	JCRB9064	LC540	Leydig cell testicular tumor
	rat	testis	JCRB9055	R2C	Leydig cell testicular tumor,steroid secreting
rat:thymus Top
	rat	thymus	IFO50078	IT-26R21	T cell differentiation factor producing, (Wistar rat)
	rat	thymus	IFO50076	IT-45R1	T cell differentiation factor producing, (Wistar rat)
	rat	thymus	IFO50077	IT-45R91	thymic fibroblast, (Wistar rat)
	rat	thymus	IFO50112	TaD-1	thymoma, keratin-positive, (ACI x BUF/Mna, F1 rat)
	rat	thymus	IFO50120	TaD-1-3	This cell line is a clone of TaD-1 cells (IFO 50112).
	rat	thymus	IFO50103	TuD-1	thymic stroma, keratin-positive, (ACI rat)
	rat	thymus	IFO50152	TuD-1-3	This cell line is a clone of TuD-1 cells (IFO 50103).
rat:thyroid Top
	rat	thyroid	IFO50270	6-23 clone 6	medullary thyroid carcinoma, neurotensin and calcitonin-producing, (WAG/RIJ rat)
tupaia:lung Top
Japan Domestic use only	tupaia	lung	JCRB0745	T-23 clone 8	normal, applicable for the mutation assay system in vitro

JCRB Cell Bank

Animal/Tissue Order List